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We are pleased to announce that Faculty of Pharmacy, Dr. A. P. J. Abdul Kalam University will be 
hosting the First International Conference on “Global Scenario in Pharmaceutical Industrial and 
Academic Research” in the enchanting University town of Indore. The Theme of the Conference is 
“Intellectual Property: Creation & Protection”.  The conference spanning over two days, includes 
scientific symposium by renowned international and national speakers which gives us an insight into 
the latest developments in pharma industry and intellectual property rights and more delegates 
expected to participate from all over India. The unique event will explore the significance of patent 
and registration of new chemical entity. We are looking forward with great enthusiasm towards your 
active participation in this event to be held in Faculty of Pharmacy, Dr. A. P. J. Abdul Kalam University, 
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International Conference  
Schedule of Event: Inaugural Session 
   Date: 26th May 2018                                        Time: 10:30 am to 11:45 am 
1. 9:00 am - 10:30 
am 
2.  





















Registration and Breakfast 
4.  
5. Opening Ceremony  
6. Floral Welcome 
7. Saraswati Vandana 
8.  
9. Welcome Speech By Organizing Chairman 
10. Dr. Arun Kumar Gupta, Dean, Faculty of Pharmacy & Principal, School of Pharmacy, Dr. 
A. P. J. Abdul Kalam University, Indore 
11.  
12. Speech of  Chancellor/Chairman 
13. Dr. Sunil Kapoor, Founder Chairman, RKDF  Group of Institution &  Dr. A. P. J. Abdul 
Kalam University, Indore 
14.  
15. Speech of Vice Chancellor’s 
16. Dr. Sandeep M Salodkar, Ho’ble Vice Chancellor, Dr. A. P. J. Abdul Kalam University, 
Indore 
17.  
18. Speech of Chief Guest (Academic) 
19. Dr. Shailendra Saraff, Ho’ble Vice Chancellor, Durg University and Vice President, 
Pharmacy Council of India, India 
20.   
21. Speech of Chief Guest (Industry) 
22. Mr. Chirag Patel, Owner & Managing Director, Inventa Holding Pvt. Ltd., Mumbai  
23.  
Speech of Guest of Honor  
24. Dr. Vinay Tripathi, Owner & Managing Director, Epoch  
25. Pharmaceutical Pvt. Ltd.,  Indore 
26.  
27. Release of Abstract Book 
28.  
29. All the Inaugural Guest & Speakers of Conference with Conference Scientific Co Partner 
Dr. Anurekha Jain, Chief Editor, Asian Journal of  
Pharmaceutical & Clinical Research, Innova Pharma Research, India  
   
Felicitation of  Guests 
 
Vote of Thanks of  Inaugural function By Convener  
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Scientific Session: Day-1  
Date: 26th May 2018         :                               Time: 12:00 noon-2:00 pm 





Session-I  Speaker 
Mr. Gabriel Silver, Clinical Research Associate, Lead –APAC, Medpace Australia 
Pty Ltd., South Yarra, Australia 
Topic : Academic and Industry Collaboration- Building a Better Future 
1:00 pm to 
02:00 pm 
Lunch 





















Session-II  Speaker 
Dr. Rao Vadlmundi, President, Common Wealth Pharmacist Association, East 
Smithfield, London UK 
Topic : Patent Vs Publication: the Academic Scenario  
 
 
Session-III  Speaker 
Dr. Mogana Sundari, Deputy Dean Pharmacy, UCSI University 
Kula Lampur, Malaysia 
Topic : Generic Medicine Entry Malaysia: The factor and challenge in the IPR status of 
innovators 
 
Session-IV  Speaker 
Dr. Manish Jindal , CEO, Quality Council of India  
Topic : Role of Quality Council of India in Pharmacy ; Overview 
 
Session-V  Speaker 
Dr. Yelena Slavko, Professor ,Kazakh National Medical University, 
Kazakisthan 
Topic : Liver Hepatotoxicity: A critical aspect in New Drug Research 






















High Tea  
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Scientific Session: Day-2 
Date: 27th May 2018         :                                      Time: 9:00 pm- 10:0pm 
09:00 am - 
10:00 am Breakfast 
Date: 27th May 2018                                              Time: 10:00 am- 01:30 pm 
10: 00 am to 
10: 45 am 
 
10: 50 am to 
11: 35 am 
 
11: 40 pm to 
12: 25 pm 
12: 30 pm to 
1: 30 pm 
Dr. Sholphan Sadykova, Professor, Kazakh National Medical 
University, Kazakisthan 
Topic : Angiogenesis on Tumor Cells role of WBC to fight Cancer 
 
 
Dr. Vinay Tripathi, Director, Epoch Pharmaceuticals  
Live Demonstration of Patent Generation & Protection 
Topic : Attainment of Novelty reality or Fantastic Live Demonstration of Patent 
generation 
 
Dr. Mustafina Kamilya, Assistant Professor,  Kazakh National Medical 
University, Kazakisthan 
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 Date: 27th May 2018         :                                      Time: 2:00 pm- 5:30pm 
2:00 pm - 
3:30 pm 
Dr. Nilesh Trivedi, Asst Director, MSME, Govt. of India 
Topic : MSME: Risk Relevant Ratio for Novel Enterprises MSME Schemes for New Aspirants 
4: 00 pm - 
05:30 pm Valedictory 
Date: 27th May 2018         :                                      Time: 5:30 pm- 6:00pm 









Dr. Shruti Kumari 
Chancellor  
Dr. A.P.J Abdul Kalam University 
 
 
I am certainly very happy to know that Faculty of Pharmacy is going to organize the 
International Conference with the theme of “Global Scenario in Pharmaceutical Industrial and 
Academic Research (Intellectual Property: Creation & Protection)” on 26-27th May 2018. 
Organizing an event does not come without an effort. It requires vision, mission and hard 
work. Conference of such nature provide a great opportunity to Pharma fraternity, not only to update 
knowledge and keep obsessed with latest developmental scenario in the respective field, but also an 
occasion for the resource persons, delegates  to exchange ideas and interact with each other.   
I take this opportunity to congratulate the organizing committee and to extend warm welcome 
to the resource persons and delegates. I thank all the national and international delegates who have 
come from various parts of the country and across the globe and we consider it as our privilege and 
honor to have you all over here. 
 
I wish you all for the grand success of this wonderful event.  
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VICE CHANCELLOR MESSAGE 
 
Dr. Sandeep M Salodkar 
Vice Chancellor  
Dr. A.P.J Abdul Kalam University 
 
 
It is a matter of great pleasure that the focal theme of the International Conference on “Global 
Scenario in Pharmaceutical Industrial and Academic Research (Intellectual Property: Creation & 
Protection)”. This conference is an aim to strengthen the national and international scenario of 
pharmaceutical industrial and academic research by offering a common platform to pharmaceutical 
scientists, researchers and students. 
The conference will stimulate the scientific tamper between students, teachers and industrial 
leaders for building the bridge between academia and industry. Scientists across the globe, especially 
from Australia, Malaysia, Russia and many other will participate as invited speakers to address the 
current need of Industry.  
Conferences are meant essentially for scientific exchange and generation of new ideas in the 
chosen field along with personal interaction and social together. I understand that a big contingent of 
national & international speakers are participating to speak on variety of topics thus enriching the 
knowledge of intellectual property rights. 
I congratulate the members of the committee for bringing out this souvenir and also express 
my warm welcome to the all national and international delegates.  
I wish the conference all the success and my heartiest congratulations to the organizing 
committee.  
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Mrs. Deepika Pathak  
Pro Vice Chancellor  




I have immense pleasure in writing this message on the occasion of the International 
Conference on Global Scenario in Pharmaceutical Industrial and Academic Research (Intellectual 
Property: Creation & Protection) hosted by the Faculty of Pharmacy, Dr. A. P. J. Abdul Kalam 
University, Indore between 26-27th May 2018.  
This conference will provide a platform to groom young scientists from all over the country 
and to bridge the researchers working in academia and other professionals through current 
technological trends. It is a high time to create research activities among the budding professionals.  
May this Conference provide greater opportunities for every member of this speciality to learn 
more and let this learning be of immense help to the community at huge.  
I congratulate the organizers for their initiative and wish the Conference all success. 
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Dr. Arun Kumar Gupta  
Dean & Professor 
Faculty of Pharmacy 
Dr. A.P.J Abdul Kalam University 
GSPIAR-2018 
 
"Learning gives creativity, creativity leads to thinking, thinking leads to 
knowledge and knowledge makes you competent.” 
 
Warm Greeting to All !!!!! 
 
It gives me an immense pleasure that Faculty of Pharmacy is organizing the International 
Conference with the theme of Global Scenario in Pharmaceutical Industrial and Academic Research 
(Intellectual Property: Creation & Protection) on 26-27th May 2018 
The conference is aimed to provide the platform for industrialists, educationists, researchers 
and students to debate and discuss on the vital need of research. The unique event will explore the 
significance of patent and registration of new chemical entity. The collective and comparative 
discussion will established the crucial insights on exciting work happening in the interface of the 
academic & industrial research. 
The GSPIAR - 2018 with your support is putting its best efforts to conduct this mega event in a 
befitting manner, considering the importance of Institute-Industry collaboration. The theme of the 
GSPIAR – 2018 seeks to not only strengthen our commitment towards the ideals of our specialty, but 
also to encourage us to look ahead and stay abreast of the latest developments in pharmaceutical 
industrial and academic research. 
The entire conference will be in parallel sessions and this conference will be addressed by 
eminent scientists and professors as key note/invited speaker while it will also attract young 
researchers, faculties and students across the country, who will take part as poster presentations.  
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I extent my warm welcome to the national and international  resource persons young 
researchers, budding Pharma professionals, eminent scientists, guests, faculties, and industrialists in 
this splendid conference and wish the conference a great success.  
  I hope all the delegates will derive maximum benefit from this event and take back fond 
memories of the Indore experience! 
 
Best wishes…………… 
JAI HIND  
 
  




Dr. Raghvendra Dubey  
Professor 
Faculty of Pharmacy 




Dear Colleagues,  
On behalf of the Faculty of Pharmacy, Dr. A. P. J. Abdul Kalam University, Indore, I heartily 
extend warm welcome to all the national and international delegates, renowned scientists and 
participants to this International Conference with the theme of Global Scenario in Pharmaceutical 
Industrial and Academic Research (Intellectual Property: Creation & Protection) on 26-27th May 
2018. The presence of other dignitaries during the two days conference is a further testimony to our 
sincere pursuits to achieve nothing less than the 'best', they have long trails of success behind them. 
The conference theme aims to create the platform for discussions that provide insights into 
the abounding opportunities in the pharma industry so that budding pharma professionals can 
upgrade their knowledge in the field of intellectual property. The conference will generate new ideas 
and inspire innovative research in future. The ability to advance research skills can be whetted to 
perfection not only through study but also via exposure to specialist in the area of research. The event 
will definitely provide us an idea for some ideal development in pharmaceuticals.  
 
I am confident that GSPIAR–2018 shall provide an effective platform for innovation, 
technology transfer and entrepreneurship concurrently meet to share and disseminate the 
knowledge and the rich experience of the pharma professionals, and to look forward solutions to the 
challenging problems. 
The organizing committee has worked hard and in different directions to make this conference 
a memorable one. It has been a good learning experience and my dear students for their endless hard 
work of months to make this conference a grander success.  My special honored gratitude to MSME 
Global Scenario in Pharmaceutical Industrial and Academic Research (Intellectual Property: Creation & Protection) GSPIAR 
for the technical support and their keen cooperation for the program. I hope that the interactions 
amongst you will create opportunities for collaborations with pharmaceutical industry and will 
provide a platform for initiating collaborative research projects. 
I intend to take this event ahead as an ideal, the motive not only is to generate discussions 
around contemporary issues, but also to propel the culture of academic exchange, which is the only 
way to achieve excellence in this field. 
I hope this event will motivate and fruitful for everybody. I assure you that we will make your 
time spent with us and in the conference a memorable one. 
 
Have a truly special and wonderful GSPIAR–2018 International Conference!! 
  





Dr. Revathi A Gupta  
Professor 
Faculty of Pharmacy 




Warm Greetings!  
It gives me immense pleasure to write a message for the international conference of Global 
Scenario in Pharmaceutical Industrial and Academic Research (Intellectual Property: Creation & 
Protection) on 26-27th May 2018 hosted by Faculty of Pharmacy, Dr. A. P. J. Abdul Kalam University, 
Indore .  
Conferences offer wonderful vistas for interaction and exchange of scientific initiatives and 
ideas. It will provide a great platform to further explore the ever expanding horizons of academic and 
industrial collaborative research.  
The members of organizing committee of GSPIAR-2018 have strived towards providing a 
comprehensive and enriching learning experience for all the delegates. Continuing the precedence 
established by earlier successful national events, we have arranged this wonderful scientific event for 
exchange of research endeavors and innovative ideas.  
Situated on the scenic and idyllic locale of Indore, the conference venue is an ideal venue for 
rejuvenating interactions and scientific exchanges. We have left no stone unturned to provide all the 
delegates a wonderful, invigorating and more interesting learning experience during your stay.  
We are hopeful that your interactions with the leading stalwarts and luminaries in the field of 
Pharma sector will further ignite the passion for undertaking meaningful and relevant research in the 
future.  
I hope that you carry back the zeal and enthusiasm of bringing industry and academic closer to 
many more needy individuals. We are also hopeful that these two days of scientific interactions will 
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inspire you to bring the best of scientific research to the most needy populace. The overwhelming 
response of various participants from across the country has been phenomenal and I thank all of 
them for sharing their research in the international conference.  
I heartily extend a warm welcome to all delegates for an extremely enriching experience in the 
august gathering of intellectual regulators, industrialist, academicians, distinguished scientists, 
research scholars and students. 
 








Honorable Chief Guest 
Academic 
Honorable Chief Guest 
Industry 
Prof. Shailendra Saraf 
Honorable Vice Chancellor 
Durg University  
Vice President, Pharmacy 
Council of India, India 
Mr. Chirag Patel  
Owner & Managing Director  




Chief Guest Valedictory 
Dr. V. Ganesan 
Centre Director 
UGC-DAE Consortium for Scientific 
Research, Indore Centre 
  










Immediate Past President 
Indian Pharmaceutical 
Association 
Dr. Mogana SR 
Deputy Dean 
Assistant Professor 
Faculty of Pharmaceutical 
Sciences, UCSI University 
Malaysia 
Mr. Gabriel Silver 
Clinical Research 
Associate, Lead –APAC, 
Medpace Australia Pty 







Dr. Yelena Slavko 
Professor  
Kazakh National Medical 
University Kazakisthan 
 
Dr. Sholphan Sadykova 
Associate Professor 















Dr. Manish Jindal 
 CEO, Quality Council of India 
NewDelhi 
Dr. Mustafina Kamilya  
Associate Professor  







Dr. Nilesh Trivedi  
Assistant Director  
MSME, Govt. of India 
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Conference Plenary Scientific Session 
 
 
PATENT VS RESEARCH PUBLICATION: THE INDIAN ACADEMIC SCENARIO 
 
DR. RAO V. S. V. VADLAMUDI 
 
 
Indian academic research particularly in the field of pharmaceutical sciences leads to more research publications than patents and it is necessary to 
take a look at what the major distinction between patenting and publishing is to understand why our academic research drifts more towards 
publications. Patenting is a process of registering an invention or discovery that did not exist or known before, while research publication is a 
documentation of an experimental observation or finding which has some novelty but need not necessarily be hitherto unknown. Often times 
research publications are reproductions of what has already been reported but with slight variations. Patents are of several kinds, but for the 
pharmaceutical field, patents more often are of the following types; product patient, process patent and application or use patent. Exploration to 
discover something that is unknown or unclear or to find a solution for a complex situation is the basis of emergence of patentable discoveries. It is 
necessary to probe further in research rather than come to a quick conclusion. Academic research in our country usually makes too many 
assumptions and hasty conclusions that depend heavily on what has already been published, there by leading to a quick publication of a low impact 
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GENERIC MEDICINE ENTRY INTO MALAYSIA: THE FACTOR AND CHALLENGE IN THE IPR 
STATUS OF INNOVATORS 
 
DR.MOGANA SUNDARI RAJAGOPAL 
 
 
Malaysia has a fast-growing domestic pharmaceutical manufacturing industry. Among Malaysia’s over 250 registered local drug manufacturing 
companies, about two-thirds are producers of traditional and herbal medicines, while the remaining third are mostly manufacturers of generic 
drugs. The market size for the pharmaceutical product globally in 2016 was estimated to reach USD1.2 trillion. In Malaysia, the market was set to 
grow from RM2.3billion in 2015 to RM3.6 billion by 2020 with an estimated annual rate of 9.5%. The availability of generic medicine equivalents of 
trademark innovator medicines is crucial for maintaining the Malaysian heavily subsidized public healthcare system, and for reducing rising 
national pharmaceutical expenditure. Up to 2013, the Malaysian generic market is growing at a rate of 12% compared to 9% for patented. There is a 
US2.9 billion revenue target for the blockbusters with patent expiration between 2013-2020. This creates opportunities for generic drug players to 
produce generic versions of the drugs and increase market share. Key factor is of course the ability of generic manufacturers to take advantage by 
preparing new products in their production pipeline, appropriate manufacturing facilities & bioequivalent to the proprietary drugs. The presence of 
a variety of government policies has had varying effects on the entry of generic medicines to the Malaysian pharmaceutical market. These policies 
are those related to intellectual property rights; medicines regulation and registration; pharmaceutical pricing and competition; and the demand-
side policies measures on generics prescribing, dispensing and consumptions. This presentation will try to elaborate on the driving force and 
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Conference Plenary Scientific Session 
 
 
ACADEMIC AND INDUSTRY COLLABORATION- BUILDING A BETTER FUTURE 
 
DR. GABRIEL SILVER 
 
 
Knowledge intensive areas such as biotechnology and health rely on innovation and research as the key to progress and growth. Collaboration is 
imperative for innovation to occur and is a vital ingredient for success. Different types of collaboration exist, from those solely aimed at expanding 
the base of knowledge, to ones focused on the production of economic value and wealth. Additionally, collaboration occurs on many levels, ranging 
from individual, to organizational. This presentation aims to explore academic and industry collaboration for the facilitation of robust research and 
for the translation of that research into measurable outcomes. A review of the current literature was undertaken as well as a review of various 
current Australian Government, Business Council, Academic Institution, and Industry websites. 
Recurrent themes emerged from the literature search pertaining to the successful collaboration of Academia and Industry. These included having 
clearly defined goals and deliverables, transparent communication through regular progress reports and conferences, and agreement being reached 
regarding intellectual properties and deadlines. Additionally, lessons were gained from the Australian landscape in regards to initiatives to promote 
and encourage successful academic and industry collaboration, both internationally and locally. 
Academic and Industry collaboration can ensure the translation of fundamental research into the market to affect health and economic outcomes on 
both a micro and macro scale. These effects can be seen in all areas of the economy, and have effect in various areas such as health, social, and 
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Conference Plenary Scientific Session 
 
 
MSME: RISK RELEVANT RATIO FOR NOVEL ENTERPRISES, MSME SCHEMES FOR NEW 
ASPIRANTS 
 
DR. NILESH TRIVEDI 
 
 
MSME is an apex body for formulating MSME policies in the country and implements promotional activities through country provided wide services 
to the Micro, Small and Medium Enterprise sector. MSME provide facilities for testing, training for entrepreneurship development, preparation of 
project and product profiles, technical and managerial consultancy, economic information in the state of Madhya Pradesh. The MSME conducts a 
large number of vocational and entrepreneurship development programmes. The programmes include Entrepreneurship development 
programmes (EDPs), Entrepreneurial Skill Development Programme (ESDP), Management Development Programmes (MDPs), Industrial 
Motivation Campaigns (IMCs) and Vocational Education Trainings. 
The aim of programs is to provide useful information on process design, manufacturing practice involved in testing and quality control. The 
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Conference Plenary Scientific Session 
 
 
PATENT GENERATION & ITS PROTECTION THE CURRENT STATUS & LIVE DEMONSTRATION 
 
DR. VINAY TRIPATHI 
 
 
Patent is an Intellectual Property right which includes product, process, trademarks, copy rights, layouts and industrial designs. In broad sense 
patent it is granted to its inventor to prevent other from own claimed invention. In India, IPR came to light when we entered into WTO as a member 
state. Patent regime has undergone a huge transformation and the awareness amongst Indians has been increased in past decade but the fact of 
conversation of patent in commercial use is observed relatively low. India in comparison to other countries has relatively good patent system which 
is designed legally better for the inventors. Numbers of amendments were made in intellectual properties in India and the latest is made in Indian 
parliament in 2005 & 2007. The recent guidelines and laws have changed the condition of patent in pharmaceuticals.  
Currently new uses of the known substance are not patentable however new dosage forms are easily patentable. Pharmaceutical patent is big 
sector in which simple admixture of substance are not patentable while major formulation changes are required for patent. In Pharmaceuticals, 
biopharmaceuticals and biotechnology products plasmids, vectors, isomers, polymorphs, other derivatives and complexes etc. are patentable. To 
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Conference Plenary Scientific Session 
 
 
LIVER HEPTOTOXICITY: A CRITICAL ASPECT IN NEW DRUG RESEARCH 
 
DR. YELENA SLAVKO 
 
 
Hepatotoxicity is a phenotype of liver Cell injury. There are multitude causes of hepatotoxicity which include drugs, toxins,  herbal and dietary 
supplements.  There are number of reactions clinically occurs due to the same which include liver necrosis, hepatitis, cholestasis, vascular changes 
and steatosis. The mechanism of such toxicity may vary in number of cases but basically they are due to directly or indirectly through reactive 
metabolites after specific receptor binding, or can react with hepatic macromolecules. The hepatotoxicity can be confirmed by variation in enzymes 
level in the liver cells. There is remarkable increase in liver enzymes enzymes alanine aminotransferase (ALT),  aspartate aminotransferase (AST) 
and bilirubin levels which indicate the liver toxicity. In Pharmaceutical new drug research collection of hepatotoxic signals is important which 
observed from non-clinical findings to clinical trials (phase I-III) and post-marketing experiences. The treatment, observation and collection of data 
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Conference Plenary Scientific Session 
 
ROLE OF QUALITY COUNCIL OF INDIA IN PHARMACY: AN OVERVIEW 
 
DR. MANISH JINDAL 
 
 
Quality council of India is established by Government of India with the aim to achieve and sustain total quality and reliability, in all areas of life, 
work, environment, products and services, at individual, organizational, community and societal levels.The QCI works on the “Quality for National 
Well Being”. It plays important role at national level in propagating, adoption and adherence to quality standards. 
In pharmaceutical sciences it works in all activities which includes education, healthcare, environment protection, governance and research. QCI  
have significant bearing in improving the quality of life and well being of the citizens. In Pharmaceuticals QCI operate National Accreditation 
program in accordance with the international standards and guides for the conformity assessment bodies certifying products, personnel, 
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Conference Plenary Scientific Session 
 
ROLE OF NATURAL PRODUCTS IN CANCER THERAPY 
   
DR. MUSTAFINA KAMILYA 
 
 
Natural products are of particular interest as cancer theraphy because of their potentially effective with  low toxicity profiles . USFDA has approved 
more than75% of natural products in past decade which are use in treatment and prevention in cancer. The use of various vitamins, minerals, and 
dietary components reduce the risk of developing specific cancers. Researches indicate that beta carotene, vitamin E, and selenium experienced a 
significant reduction in overall mortality in Stomach Cancer. Clinically it is also concluded that the dietry use of Selenium supplementation & 
alphatocopherols significantly decreased risk of prostate cancer.  
The bioactive curcuminoids is used as chemopreventive due to its antioxidant, anti-inflammatory effect and ability to inhibit activation of 
carcinogens by cytochrome enzymes.  The oil containing Omega-3 fatty acids, such as docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) 
prevent cancer by inhibit the formation of proinflammatory and procarcinogenic eicosanoids, such as prostaglandins. 
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Conference Plenary Scientific Session 
 
 
ANGIOGENESIS ON TUMOR CELLS ROLE OF WBC TO FIGHT CANCER 
 
DR. SHOLPHAN SADYKOVA 
  
 
Tumor angiogenesis signifies a way for cancer cells to function and succeed for self-sustained growth. The inhibition of tumor-induced angiogenesis 
may restrict metastasis and tumor growth. Leukocytes are cells of defense. In this defensive reactionthe blood and lymphatic vascular system are 
essential partners becauseactivated endothelial cells stimulate leukocyte recruitment at inflammatory sites and then new blood vessel formation 
which process called angiogenesis. theantigens and antigen-presenting cells transportto lymph nodes, where they stimulate naive T and B 
lymphocytes to elicit an antigen specific immune response. The angiogenic process in tumors can be classified into three main phases: 
inflammatory, proliferative, and remodeling. During the inflammatory phase the leukocytes and monocytes are produced to the tumor. In the 
proliferative phase, it produce ECM components such as collagenin combination with the proliferation of endothelial cells there is increased 
proliferation of fibroblasts. The hyperpermeability during the proliferation stage is vital for effective tumor angiogenesis and local degradation of 
the basement membrane. This permits for the relief of heparin, platelet factors, growth factors and proteases thatassociate to endorse the 
formation of new blood vessels as well as to induce their migration and sprouting into the local stroma.  The blood vessels are remodeled and 
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S. No. Abstract Code Title of Abstract Author Name Page No. 
1 GSPIAR/2018/IC-01 
Formulation and Evaluation of Herbal Hair 
Cream Using Hibiscus Rosa-Sinensis 




Effects of Ethanolic Stem Bark Extract of 
Polyscias Fulva on Monosodium Glutamate-
Induced Uterine Fibroids in Wistar Rats 




The Evaluation of Analgesic & Anti-
Inflammatory Action of Aloe Barbadensis Millar 
Extract In Albino Rat 
Deepika  Bairagee 3 
4 GSPIAR/2018/IC-04 
Formulation, Characterization and Evaluation of 
Gastroretentive Tablet of Ranitidine HCl By 
Using HPMC and Carbopol 
Deepika  Bairagee 4 
5 GSPIAR/2018/IC-05 
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FORMULATION AND EVALUATION OF HERBAL HAIR CREAM USING HIBISCUS ROSA-SINENSIS 
 
SONAM BHALAWE*, PRIYANKA SINGH, SAMRUDHI MUNGRE 




The purpose of this research was to develop and evaluate a herbal hair cream using Hibiscus rosa-sinensis with acceptable properties that would 
replace the ongoing use of synthetic marketed creams which shows harmful effects, based on market and public survey carried out on crude drugs 
used presently for herbal hair creams gives us clue for selection of drugs for formulation of oil, cream and gel for hair growth promoting activity. 
Hibiscus has been reported to have been used as anti-asthmatic agent, anti-inflammatory, antipyretic and possess anti-tumor and anti-convulsant 
properties. Several studies have revealed presence of antimicrobial properties in flowers of Hibiscus rosa-sinensis. 
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EFFECTS OF ETHANOLIC STEM BARK EXTRACT OF POLYSCIAS FULVA ON MONOSODIUM 
GLUTAMATE-INDUCED UTERINE FIBROIDS IN WISTAR RATS 
 
P. ODAYA KUMAR1*, REVATHI GUPTA1, KACHIKO GEOFFREY2 




The aim of this study was to evaluate the curative property of a stem bark extract of Polyscias fulva on monosodium glutamate (MSG)-induced 
uterine leiomyoma in rats and its safety for use. It was an experimental kind of study. The research was carried out under the department of 
pharmacology and the department of pharmaceutical chemistry from January 2016 to April 2017. Phytochemical screening was performed on an 
ethanolic and aqueous extract of the stem bark of Polyscias fulva. Curative studies (measuring plasma estradiol, triglycerides and ratios of uterus 
weight to body weight) using 50,100 and 200 mg/kg of extract, per os, on 800 mg/kg MSG-induced uterine leiomyoma in Wistar rats was 
conducted. Acute and delayed toxicity of Polyscias fulva bark extract was tested. The outcomes were that the monosodium glutamate administered 
to rats significantly elevated their plasma total cholesterol and estradiol levels. It also increased their uterus weight and size (indicating 
hyperplasia). Curative treatment reduced significantly the elevated plasma total cholesterol and estradiol level. Treatments also significantly 
decreased the elevated uterus weight. The lethal dose was greater than 5000 mg/kg p.o. The conclusion was that The ethanolic stem bark extract of 
Polyscias fulva contains phytochemicals significantly decreases elevated levels of plasma cholesterol, estradiol, as well as uterus size and weight 
suggesting its efficacy as a curative agent for uterine fibroids. The extract is very safe for use.  
Keywords: Monosodium glutamate; Uterine leiomyoma; Plasma estradiol; Plasma total cholesterol 
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THE EVALUATION OF ANALGESIC & ANTI-INFLAMMATORY ACTION OF ALOE BARBADENSIS 
MILLAR EXTRACT IN ALBINO RAT 
DEEPIKA BAIRAGEE*, SWETA KULKARNI, RAJU CHOUKSE, ARUN K GUPTA 




The aim of the present study was to evaluate analgesic and anti-inflammatory action of Aloe Barbadensis Millar extract in Albino Rat. This study 
provides information regarding identification of cincole related compound that have anti inflammatory activity through the specific inhibition of 
COX-2. Overall the cincole preparation use in this study was found to inhibit COX-2 approximately three-fold more than COX-1, and this property 
should contribute to the beneficial anti-inflammatory activity of Aloe barbadensis product. The result of the present study has shown that the food 
extract of the investigated plant exhibited very high anti-inflammatory activity, this activity may be linked with the presence of poly phenolic 
compound present in the extract main constitute of aloe barbadensis which are repeated to be anti-inflammatory, antiasthamatic, analgesic, anti-
oxidant activity and this finding are in concordance with over results. Carrageenan induced has been commonly used as an experimental animal 
model for acute inflammation and is believed to be biphasic. The extract significantly inhibited paw edema which was induced by carrageenam in 
the 2nd phase; this effect is similar to that produced by non-steroidal anti-inflammatory drug. 
Keywords: Aloe vera; Carrageenan; Paw edema; Inflammatory; Analgesic  
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FORMULATION, CHARACTERIZATION AND EVALUATION OF GASTRORETENTIVE TABLET OF 
RANITIDINE HCl BY USING HPMC AND CARBOPOL 
DEEPIKA BAIRAGEE*, SWETA KULKARNI, NEETU CHOUDHARY, RAJU CHOUKSE 




The main objective of the present work was the formulation, characterization and evaluation of gastroretentive tablet of Ranitidine HCl by using 
hydroxypropyl methyl cellulose (HPMC) and Carbopol as polymers. Floating tablet of Ranitidine HCl and different polymers were prepared to 
optimize the drug content, floating ability, swelling index and drug release profile. The blended powder and granules were evaluated for different 
pre-compression parameters, like mean particle size, angle of repose, tapped density, bulk density, compressibility index, Carr’s index and 
Hausner’s ratio. The tablets were evaluated for post-compression features including hardness, friability, weight variation, buoyancy, swelling index 
and drug content.  Ten different formulations F1-F10 of Ranitidine HCl were formulated by variation in the ratio of HPMC and Carbopol. From the 
investigation it is found that the Ranitidine HCl F1 formulation was found to be better by considering all the evaluated parameters like floating lag 
time, total floating time, hardness, friability, weight variation and percentage drug release.  
Keywords: Gastroretentive Tablet; Ranitidine HCl; HPMC; Carbopol; Buoyancy  
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POTENTIAL APPLICATIONS OF CARBON NANOTUBES AND NANOFIBERS 
RAGHVENDRA* 




Nanomaterials, are materials with structural units on a nanometer scale in at least one direction. Material properties become different on the 
nanoscale: for example, the theoretical strength of materials can be reached or quantum effects may appear. One-dimensional and quasi-one-
dimensional materials such as nanotubes and nanowires demonstrate many extreme properties that can be tuned by controlling their structure and 
diameter. Carbon can be made to form tubular microstructure called filament or fiber. The unique properties of carbon fibers have expanded the 
science and technology of composite materials in recent decades. Nanotubes, nanowires, and nanofibers are not only brilliant tools for studying 
one-dimensional phenomena, but they are also the most important and promising nanomaterials and nanostructures. The role of nanomaterials in 
industries is growing. Nanofibers are already used for insulation and reinforcement of composites, and many materials and structures 
incorporating nanotubes and nanowires are under development. Nanotechnology is one of the most important technologies in this century and it is 
evoking a new industrial revolution. Nanotechnology is changing basic research in the fields of information technology, biological science, 
environmental science, energy sources, material science, and others. The new trends of industrial elements toward small features are fast 
transmission, high density, low energy cost and high production. Nanomaterial containing nanostructures are the best material to fulfil these needs. 
Carbon nanotubes are among the most broadly discussed, researched and applied. Carbon nanotubes are microscopic in nature and tube-shaped in 
structures, which essentially have a graphite composition sheet rolled into a tube.  
Keywords: Carbon Nanotubes; Nanofibers; Nanomaterials; Nanotechnology 
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FORMULATION AND EVALUATION OF MUCOADHESIVE MICROSPHERE IN 
GASTRORETENTIVE DELIVERY OF VENLAFAXINE HCL 
KUMKUM SHARMA, RAGHVENDRA* 




In the present work the formulation and evaluation of the mucoadhesive Venlafaxine HCl microspheres using Hydroxy Propyl Methyl Cellulose K4M 
as a polymer was studied. Venlafaxine HCl is a new generation serotonin reuptake inhibitor drug showing effective antidepressant properties, 
having a short bioavailability of 12.6% and biological half-life of 5 hours. By simple emulsification phase separation method using glutaraldehyde as 
a crosslinking agent the microspheres of Venlafaxine HCl were prepared. Fifteen preliminary trail batches KA1-KA15 of microspheres were 
prepared by using different volume (10ml to 50ml) of glutaraldehyde (25% v/v aqueous solution) as crosslinking agent, crosslinking time of 1 to 3 
hours and the polymer to drug in 2:1 ratio. From those fifteen preliminary trial batches, the optimized formulation was selected based on the 
percentage of mucoadhesion, stirring speed, (500, 800 and 1000 rpm), drug entrapment efficiency, and particle size. The drug and polymer 
compatibility study was carried out by using FTIR and the stability study was also carried out for the main formulation. The optimized formulation 
exhibited a high drug entrapment efficiency of 70% and a swelling index 1.57, % mucoadhesion after 1hour was 80% and the drug release was also 
sustained for more than 12 hours. As the concentration of glutaraldehyde increased, the mucoadesiveness decreases and there was no significant 
effect in time. 
Keywords: Venlafaxine; GRDDS; Mucoadhesive microsphere; FT-IR; Mucoadhesion 
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EFFECT OF VARIOUSPOLYMERSAND THEIR CONCENTRATION ON RELEASERATEOFMATRIX 
TABLET OFMETOPROLOL TARTRATE 
MANOHAR CHOUHAN*, HARIT KUMAR RAWAL, SURENDRA SINGH DAKHAA, ARUN K.GUPTA 




The present study was done the different concentrations of various polymers on in vitro drug release from sustained release matrix tablet. HPMC 
K15 M (Hydrophilic) and ethyl cellulose (Hydrophobic) were used as rate controlling polymer for controlled release drug delivery system. Matrix 
tablets of Metoprolol tartrate were fabricated by varying the concentrations of both polymers via wet granulation method.  Tablets were 
characterized for physical properties like loose bulk density, tapped density, angle of repose, Carr’s index, Hausner´s ratio; all formulations showed 
satisfactory properties. Tablets were evaluated for uniformity of weight, thickness, hardness, percentage (%) friability and in vitro release studies. 
The in vitro release of metoprolol tartrate was evaluated and found that the preliminary batches containing the decrease amount of rate controlling 
polymer (HPMC K15 M) showed the faster release and the tablet were completely dissolved in 5-6 hours. For the extending the release profile 
added ethyl cellulose, it increases the dissolution rate and the drug is sustained release upto12hrs using HPMCK15M and EC in 1:1 ratio. The 
release rate of Metoprolol tartrate from matrix tablets followed nearly Higuchi kinetics vianon-Fickian diffusion controlled mechanism. This study 
reveals that a combination of HPMC K15M and ethyl cellulose in the ratio of 1:1 (F-5) showed best grade for controlling the release rate. The 
optimized formulation has drug release profile up to 12 hours. 
Keywords: Hydrophilic; Hydrophobic; Extended release; Wet Granulation. 
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SOLUTION COMBUSTION SYNTHESIS OF ZINC OXIDE NANOPARTICLES FOR WATER 
TREATMENT 
M. VISHWAS* 




Zinc oxide (ZnO) nano particles (NPs) were synthesized by solution combustion method using sugar as fuel. The synthesized nano particles were 
annealed at different temperature and subjected to characterization by x-ray diffraction (XRD), scanning electron microscope (SEM) and energy 
dispersive x-ray spectroscopy (EDAX) in order to study the structural, morphological and chemical composition of the sample. The XRD results 
revealed that the ZnO NPs are highly crystalline, having hexagonal wurtzite crystal structure. The SEM images showed that ZnO NPs prepared in 
this study are spherical in shape. The size of ZnO NPs increased with an increase in annealing temperature.  The ZnO NPs were subjected to photo-
catalytic degradation of organic dyes mixed in de-ionized water under UV and visible light. ZnO NPs showed excellent photo-catalytic activity under 
UV light. The photo-catalytic activity of ZnO NPs was investigated by varying the annealing temperature, concentration of dyes, dose and duration 
etc.  
Keywords: ZnO; Combustion synthesis; Photo-catalysis; SEM; XRD; EDAX 
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FORMULATION AND EVALUATION OF SUSTAINED RELEASE TABLET OF METOPROLOL 
SUCCINATE BY HOT MELT EXTRUSION TECHNIQUE 
ASHOK KOSHTA*1, NARENDRA VYAS1, ANKUR JOSHI1, MOHIT CHATURVEDI2, SAPNA MALVIYA1, ANIL KHARIA1 




The present study deals with the formulation and evaluation of sustained release tablet of Metoprolol Succinate by Hot Melt Extrusion Technique. 
The investigations were carried out on the preparation of tablets by Hot Melt Extrusion technique to improve the dissolution property of highly 
soluble drug Metoprolol Succinate. Based on the literature studies, various excipients like povidone and ethyl cellulose white were chosen. In the 
Preformulation studies, based in the solubility of Metoprolol Succinate in different non-volatile solvents, water & phosphate buffer 6.8 was selected 
as drug solvent for in-vitro dissolution studies. The compatibility between the selected drug and the carrier was tested by physical compatibility 
method and it was found to be compatible without any interactions. Formulation of tablets was done by using Metoprolol Succinate Hot Melt 
Extrusion technique and evaluated for dissolution. Out of various formulations prepared, it was observed that F7 showed 96% of the drug release 
within 2 hours compared to innovator product. This was verified by calculating Similarity factor for trail F7 and was found to be 77.1 %, which 
confirm that it is most similar to the innovator product. Hence F7 was selected as optimized formulation and evaluation for stability as per ICH 
Guidelines for three months. 
Keywords: Sustained Release; Metoprolol Succinate; Hot Melt Extrusion technique; dissolution 
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DRUG UTILIZATION EVALUATION STUDY IN HOSPITAL WITH REFERENCE TO ANTIBIOTIC 
AGENTS 
NARENDRA VYAS*, ASHOK KOSHTA, ANKUR JOSHI, SAPNA MALVIYA, ANIL KHARIA 




The present study was carried out to obtain prescribing pattern of drugs specially antibiotics in both prophylaxis & empirical directed therapy. 
Antibiotics are a group of drugs with the most potential impact on morbidity and mortality in the developing world. Misuse of antibiotics is a crucial 
factor in the genesis of microbial resistance. A prospective analysis of inpatient records over a five-month period was carried out at the hospital. A 
total of 300 patients of either sex were taken for antibiotics use pattern study. In the first phase of the study; the pattern of antibiotics use in the 
inpatient department of the hospital was evaluated, In the Second phase of the study, antibiotic use for surgical prophylaxis was evaluated. A total 
of 300 patients were surveyed for antibiotic use pattern study; 100 patients for surgical prophylaxis survey for 5 months. The average age of the 
patients was 60 years. Total no. of patients who received antibiotics during the study period was 223. Out of 223 patients, 27 patients received 
antimicrobials for surgical prophylaxis and rest of 196 patients received antimicrobials as empirical therapy. Out of 223 patients who received 
antimicrobials, total of 112 patient’s specimens were sent for culture. Out of these 112 patients, 23 patients had positive culture reports and 17 
patients received antimicrobials as per the culture sensitivity reports. 98 patients received more than 10 drugs and 78 patients received 3 or more 
antimicrobials during their stay in the hospital. A total of 1870 drugs were prescribed. Pantoprazole was the most commonly prescribed drug; 
Tobramycin was the most commonly prescribed antibiotic. The evaluation of use of antibiotics for surgical prophylaxis showed that out of 100 
patients who were enrolled for surgical prophylaxis study, 75% patients received more than a single dose of antibiotic in operation which lasted for 
less than 4 hours. In 60% patients, antibiotic given before surgery was continued postoperatively; prescribed at the time of discharge, also7% 
patients received cefazolin; fluoroquinolones were used in 15% cases. 8 patients received single dose of antibiotic. 80 patients received more than 
one antibiotic. Minimum number of antibiotic/s prescribed to a patient was 1. Maximum numbers of antibiotic/s prescribed to a patient were 4. 
The use of antimicrobials seems to be high (79.8%) in in-patient department of this hospital. Although there are no gold standards for the extent of 
use of antimicrobials in patient settings. However, the average numbers of drugs per encounter, the percentage of encounters with an antibiotic 
prescribed are the areas which need further consideration to improve the quality of health care. Reserve antibiotics were not present among top 5 
drugs showed that reserve antibiotics were used efficiently. This should be encouraged; in surgical prophylaxis non compliance with the Standard 
treatment guidelines (STG’s) for antibiotic usage was observed therefore the present study findings called for a review of antibiotic prescribing 
practices. 
Keywords: Antibiotics; Drug utilization; Surgical prophylaxis.  
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EXPLORING THE STRUCTURAL REQUIREMENTS FOR TYROSINE KINASE INHIBITORY 
ACTIVITY THROUGH MOLECULAR DOCKING APPROACH 
NIDHI GUPTA*, LOVE KUMAR SONI 




To gain more fruitful structural insights towards tyrosine kinase inhibitory activity against EGFR and HER-2 receptor tyrosine kinase enzyme. In 
this study, docking analysis has been carried out through Molegro Virtual Docker (MVD) 6.0 software on pdb 3RCD. The docking study was 
performed to observe the interaction of all compounds with the receptor and to examine the agreement between the docking pattern and 
predictive activity of the validated pharmacophore. Docking study revealed that some of the compounds was nicely bound with ATP binding site of 
kinase inhibitor receptor through hydrophobic, H-bonding and steric interactions.  These compounds show Hydrogen bonding interaction via 
binding with Met801A amino-acid residues. Rather than hydrogen bonding interactions, compound also exhibited hydrophobic and steric 
interaction with Asp863A, Ala751A, Met801A, Leu800A and Leu852A amino-acid residues. Kinase Inhibition study suggested that hydrogen 
bonding,and hydrophobic interaction plays significant role in its inhibitory activity. 
Keywords: Tyrosine kinases; Thiazolidin-4-one; Docking; Hydrogen bonding interaction; Hydrophobic interaction. 
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NEUROPROTECTIVE AND ANTI-AMNESIC ACTIVITY OF MAJORANA HORTENSIS LEAVES IN 
SCOPOLAMINE INDUCED AMNESIA IN RATS 
ANKUR JOSHI 1*, NEELESH MALVIYA 2 




The present study was carried out to investigate neuroprotective and antiamnesic activity of Majorana hortensis leaves in scopolamine induced 
amnesia in wistar rats. Hydroalcholic extract of Majorana hortensis at a dose level of 100mg/kg and 200mg/kg was used for present study. Wistar 
rats (180-200 g) were trained for elevated plus maze. Every animal received 15 trials with inter trial duration of 15 s for 5 days. Scopolamine (3 
mg/kg, i.p) was used for induction of amnesia in different groups (n = 6). Piracetam was used as a standard (120mg/kg). Various biomarkers 
enzymes of brain like superoxide dismutase (SOD), catalase (CAT), contents of thiobarbituric acid reactive substances (TBARS) and reduced 
glutathione (GSH) in whole-brain homogenates and Acetylcholinesterase (AChE) activity was evaluated. Effect of Majorana hortensis extract was 
evaluated and compared to a standard drug, Piracetam. Scopolamine treatment significantly (p < 0.01) reduced the avoidance response compared 
to control. Majorana hortensis extract treated groups shown significant (p < 0.01) increase number of avoidance response as compared to 
scopolamine treated groups, increased oxidative stress in brain after scopolamine treatment. Decrease in oxidative stress in the groups treated with 
extracts. AChE activity was also improved after Majorana hortensis treatment. The results of the study indicate that the hydroalcholic extract 
of Majorana hortensis leaves have neuroprotective and antiamnetic activity which supports the traditional claims. 
Keywords: Majorana hortensis; AChE; Amnesia; SOD; GSH; MDA 
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QSAR STUDIES OF BENZIMIDAZOLE DERIVATIVES AS POTENTIAL ANTICANCER AGENTS 
M.C. SHARMA* 




Two dimensional quantitative structure-activity relationship studies for benzimidazole derivatives potential anticancer activity were performed using 
partial least square (PLS) regression method. The data set had 45 structurally diverse molecules and the obtained model was validated by predicting 
inhibition of twenty compounds as test set. Developed model has high predictive power characterized by r2 = 0.8016 and q2 = 0.6998 respectively. 
Substitution of electron donating group in the molecule will enhance the positive influence to the activity. Analysis of model has demonstrated the 
important role of Estate numbers features of molecules on their anticancer activity and provides details on the fine structure and activity. 
Keywords: QSAR; Validated; Anticancer Activity  
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STUDY OF ANTIOBESITY ACTIVITY IN CORRELATION WITH ANTIDIABETIC 
DEEPAK JAIN 1,2*, ANUREKHA JAIN3 
1Pacific Academy of Higher Education and Research University, Udaipur, Rajasthan, India.2B.R. Nahata College of Pharmacy, MU 




The present study was designed to investigate antidiabetic and antiobesity study of extract of Momordica charantia, Eugenia jambolana, Ziziphus 
mauritiana and Acacia catechu using obese diabetic rats’ model. Rats received high-fat diet and alloxan was injected intraperitoneal to rats for 
induction of diabetes. In the preventive experiment, diabetic rats received Momordica charantia (200 & 400 mg/kg/day p.o) Eugenia jambolana 
(200 & 400 mg/kg/day p.o), Ziziphus mauritiana (200 & 400 mg/kg/day p.o), Acacia catechu (200 & 400 mg/kg/day p.o) and aqueous extract of all 
extract (100 & 200 mg/kg/day p.o). Diabetic rats were also treated with Glybencliamide (5 mg/kg p.o.) and Orlistat (60 mg/kg/day p.o.) as 
reference standards. Extract of Momordica charantia, Eugenia jambolana, Ziziphus mauritiana and Acacia catechu  significantly (p<0.05) inhibited 
body weight gain, blood glucose, triglyceride, total cholesterol, LDL, VLDL, HDL-C, SGPT, SGOT, fasting blood glucose in a dose dependent manner. 
Extacts-treated rats at doses of 200 and 400 mg/kg improved dyslipidemia in HFD-induced obese rats by enhancing their lipid metabolism when 
compared to the high fat diet (HFD) control. Taken together, extract of Momordica charantia, Eugenia jambolana, Ziziphus mauritiana Acacia 
catechu and aqueous extract of all extract has potential as a preventive agent for type 2 diabetes mellitus (and possibly obesity) and deserves 
clinical trial in the near future. 
Keywords: Momordica charantia; Eugenia jambolana; Ziziphus mauritiana; Acacia catechu; Antidiabetic; Antiobesity. 
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TWO DIMENSIONAL QUANTITATIVE STRUCTURE ACTIVITY RELATIONSHIP STUDY 2-
AMINOBENZOTHIAZOLE DERIVATIVES AS ANTICONVULSANT ACTIVITY 
BHAGAT SINGH CHOUHAN*, LOVE KUMAR SONI* 




Two dimensional quantitative structure activity relationship (2D-QSAR) studies were carried out on a series of novel 6-substituted 2-
aminobenzothiazole analogues to elucidate the structural properties required for anticonvulsant activity. The study were performed using multiple 
linear regression method giving r2 = 0.88 and q2 = 0.63 for Hansch analysis, r2 = 0.82 and q2 = 0.68 for Fujia-Ban analysis respectively. Thus this 
validated model provides an important structure insight for designing of novel anticonvulsant agents.   
Keywords: 6-substituted-2-aminobenzothiazole; Anticonvulsant activity; 2D-QSAR; SMLR. 
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ANTI-ANEMIC ACTIVITY OF HYDRO-ALCOHOLIC EXTRACT OF SEEDS OF PRAECITRULLUS 
FISTULOSUS IN PHENYLHYDRAZINE INDUCED ANEMIC RATS 
CHANDRAKANTA KUSHWAH*, DEEPANSHU GUPTA, ANKUR JOSHI, SAPNA MALVIYA, ANIL KHARIA 




This research was envisaged to carry out the anti-anemic activity in hydro-alcoholic extract of seeds of Praecitrullus fistulosus in phenylhydrazine 
induced anemic rats. Phenylhydrazine (60mg/kg) was given intraperitoneally in rats for two days to induce anemia. The animals were divided into 
5 groups of 6 animal each. Group 1 was known as normal control group, Group 2 was known as anemic control group, Group 3 was known as 
standard reference control group given with Vit. B12, Group 4 was known as test control-I given with 100mg/kg of hydro-alcoholic extract of seeds 
of Praecitrullus fistulosus, Group 5 was known as test control-II given with 200mg/kg of hydro-alcoholic extract of seeds of Praecitrullus fistulosus. 
All the test drugs were given for 13 days through oral route once in a day. On 14th day blood was taken out through tail puncture and was subjected 
to the estimation of RBC, Hb and percentage Haematocrit. Both the hydro-alcoholic seeds extract of and Vit. B12 significantly increase the HB, RBC & 
percentage Haematocrit level. The results of the study indicate that the hydro alcoholic extract of Praecitrullus fistulosus seeds exhibits the anti-
anemic activity. 
Keywords: Anemia; Anti-anemic activity; Hydro-alcoholic extract; Praecitrullus fistulosus; Vit. B12. 
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FORMULATION OF OPTIMIZED BATCHES OF MUCOADHESIVE MICROSPHERES INTO 
CAPSULE FOR HELICOBACTER PYLORI ERADICATION 
ANU HARDENIA1*, ARUN K GUPTA2, SHIV HARDENIA1 
1Department of Pharmacy, SGVU, Jaipur, Rajasthan.2RKDF Institute of Pharmaceutical Sciences, Dr. A. P. J. Abdul Kalam University, Indore, 
Madhya Pradesh 
Email: anuhardenia7@gmail.com  
Abstract 
The present work aimed at formulation and development of mucoadhesive microspheres containing Amoxicillin and Famotidine for the effective 
treatment in eradicating Helicobacter Pylori and for use in gastric and duodenal ulcers. The mucoadhesive microspheres were prepared by using 
emulsion solvent evaporation technique with carbopol-934P and ethyl cellulose as polymers. Initially 27 formulations were prepared for each drug 
with the help of 33 Factorial designs and were optimized for dependent results. Finally the optimized batches of mucoadhesive microspheres after 
evaluation from each drug (A27 and F25) were formulated in final Capsule form. The final capsule batches were evaluated for different parameters 
like Weight variation, Content uniformity and Drug release. The batches A27 and F25 showed the highest drug entrapment of 66% and 69% and 
were considered as final optimized batches. The formulated batches passed the weight variation test with permissible limits and had shown the 
content uniformity of 90% and 92%. The cumulative drug release within 12hrs was shown to be 81.03% and 84.09% accordingly. 
Keywords: Muco-adhesive Microspheres; Helicobacter Pylori; Factorial designs; Optimization 
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ANTIULCER ACTIVITY OF AQUEOUS EXTRACT OF FRUITS OF PRAECITRULLUS FISTULOSUS IN 
ALBINO RATS 
MALVIYA SAPNA*, JOSHI ANKUR, VYAS NARENDRA, KHARIA ANIL 
Modern Institute of Pharmaceutical Sciences, Indore-453111 (M.P.), India 
Email: drsapnaneeleshmalviya@gmail.com 
Abstract 
Ulcer affects nearly 10%-15% of world population can be developed inside the inner lining of the stomach (gastric ulcer) or the small intestine 
(duodenal ulcer).The present study was carried out to investigate antiulcer activity of aqueous extract of fruits of Praecitrullus fistulosus In present 
study the aqueous extract of Praecitrullus fistulosus was subjected to acute oral toxicity study as per OECD guidelines. Based on the observations of 
toxicity studies dose of 300 mg/kg was selected for the study. The pretreated animals were induced ulcer using 80% ethanol. Various parameters 
such as area of gastric lesion, nonprotein sulfhydryls (NP-SH) concentration, gastric wall mucus concentration, total acidity and volume of gastric 
content; and histopathological parameters like hemorrhage, edema, erosion, ulceration were studied in the control group and pretreated groups. 
The antiulcer activity was compared with standard drug lanzoprazole (30 mg/kg). Pretreatment with aqueous extract of Praecitrullus fistulosus 
fruits showed significant (P< 0.05) decrease in the total acidity and ulcer index. The extract treated group also showed significant decrease in 
gastric lesion and NP-SH and gastric wall mucus concentrations. Improvements in all histopathological parameters were observed in the extract 
treated group. Overall the aqueous extract of Praecitrullus fistulosus fruits was shown to possess significant (P< 0.05) antiulcer property in albino 
rats. The result of the study indicates antiulcer activity of aqueous extract of Praecitrullus fistulosus which supports the traditional claims in folklore 
medicine. 
Keywords: Antiulcer activity; Praecitrullus fistulosus; Gastric ulcer; Nonprotein sulfhydryls (NP-SH) concentration; Gastric lesion. 
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SEPRATION OF E, Z ISOMERS OF DOTHIEPIN AND DOXEPIN BY HPLC 
KIRTI MALVIYA*, ASHOK KOSHTA, NARENDRA VYAS, SAPNA MALVIYA, ANIL KHARIA 




Dothiepin, N, N-dimethyl-3-(dibenz [b,e]thiepin-11(6H)-ylidene) propylamine is antidepressant drug useful in the treatment of mild to moderate 
endogenous depression. It differs in structure form amitriptyline by the presence of sulphur atom in the central ring, which leads to the formation 
of E and Z isomer. The Z isomer is more active then E isomer. Dothiepin is a Racemic mixture of E and Z isomers. As with related tricyclic 
antidepressant agents, the induced elevation of mood may be accompanied by atropine like anticholinergic side effects such as dryness of mouth 
and sedation, Dothiepin is not recommended for use in children. Dothiepin blocks the reuptake of serotonin and noradrenaline. It has antagonistic 
effects on various postsynaptic receptors. Doxepin N, N-dimethyl-3-(dibenz [b,e]oxepin-11(6H)-ylidene) propylamine also differs in structure form 
amitriptyline by the presence of Oxygen atom in the central ring, which leads to the formation of E and Z isomer. The Z isomer is more active then E 
isomer. Doxepin is a Racemic mixture of isomers. As with related tricyclic antidepressant agents, the induced elevation of mood may be 
accompanied by atropine like anticholinergic side effects such as dryness of mouth and sedation. Doxepin is not recommended for use in children. 
Doxepin is relatively mild and is used for low level anxiety depression. The racemic mixtures of Dothiepin, N, N-dimethyl-3-(dibenz [b,e]thiepin-
11(6H)-ylidene) propylamine and Doxepin N, N-dimethyl-3-(dibenz [b,e]oxepin-11(6H)-ylidene) propylamine are separated  by using HPLC 
techniques to increase the Z isomer concentration which is more effective than E isomer. 
Keywords: Dothiepin; Doxepin; Isomer; Antidepressant activity. 
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ANTI-ANEMIC ACTIVITY OF HYDRO-ALCOHOLIC EXTRACT OF SEEDS OF COCCINIA GRANDIS 
IN PHENYLHYDRAZINE INDUCED ANEMIC RATS 
DEEPANSHU GUPTA*, CHANDRAKANTA KUSHWAH, ANKUR JOSHI, SAPNA MALVIYA AND ANIL KHARIA 




The main aim of this current research was to evaluate the anti-anemic activity in hydro-alcoholic extract of seeds of Coccinia grandisin 
phenylhydrazine induced anemic rats. To induce anemia phenylhydrazine (60mg/kg) was administered intraperitoneally in rats for two days. The 
animal was divided into 5 groups containing 6 animal each. 1st group was served as normal control group, 2nd group was served as anemic control, 
3rd group was served as standard reference control administered with Vit. B12 complex, 4th group was served as test control-I administered with 
100mg/kg of hydro-alcoholic extract of seeds of Coccinia grandisand 5th group was served as test control-II administered with 200mg/kg of hydro-
alcoholic extract of seeds of Coccinia grandis. All the test drugs were given for 13 days daily through oral route. On 14th day blood was withdrawn, 
through tail puncture and subjected to the estimation of RBC, Hb and percentage Haematocrit. Both the hydro-alcoholic seeds extract of Coccinia 
grandis and Vit. B12 significantly increase the Haemoglobin, Red Blood Cells& percentage Haematocrit level. The results of the study indicate that the 
hydro alcoholic extract of Coccinia grandis seeds exhibits’ the anti-anemic activity. 
Keywords: Anemia; Anti-anemic activity; Hydro-alcoholic extract; Coccinia grandis; Vit. B12.  
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FORMULATION AND FORMULATION STUDY OF HERBAL SUPPOSITORY OF VITEX NIGUNDO 
HITESH KUMAR PARMAR* 




The dried leaves of Vitex Negundo (Family: verbenaceae) has esteemed medicinal properties and many uses are referred in Ayurveda. In the 
present study attempt was made to formulate suppositories of Vitex negundo extract for its anti-inflammatory and analgesic activity. The 
formulations of suppositories with water soluble base were prepared and evaluated for in vitro test from the evaluated parameter it was found that 
the herbal formulation of suppositories significant for local effect .  
Keywords: Ayurveda; Vitex Negundo; Herbal formulation; Suppositories  
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FORMULATION AND EVALUATION OF BILAYER TABLET OF INDAPAMIDE AND 
TELMISARTAN FOR THE TREATMENT OF HYPERTENSION 
SWETA KULKARNI*, DEEPIKA BAIRAGEE, NEETU CHOUDHARY, RAJU CHOUKSE 
School of Pharmacy, Dr APJ Abdul Kalam University, Indore, M.P 
Email: sweket@gmail.com  
 
Abstract 
The present study was explored to fomulate bilayer tablet of Indapamide a Thiadize diuretic with combination of Telmisartan an Angiotensin -II 
receptor antagonistas a fixed dose combination. The main objective of present invention was to provide stable dual release pharmaceutical 
composition used for treatment of hypertension, chronic stable angina and other related cardiovascular diseases comprising combination of 
therapeutically effective amount of angiotensin- II  receptor antagonist and a diuretic agent, either its lexemic or enantiomer or its salts forms. The 
present invention discloses stable pharmaceutical composition of two active ingredients, formulated in a single doses form providing different 
release profile comprising dual release drug absorption system .To combine both the drugs belonging to different classes of antihypertensive, 
having different mechanism of action and different pharmacokinetic parameters into a single unit dosage form to provide single pill convenience, 
additive effects and reduce side effects associated with mono-therapy. The tablets were evaluated for various tests and were found to show 
compliance with pharmacopoial specifications. Both the drugs showed highest release rate at lower concentration of polymers. Stability tests 
showed no any notable change in release rate and drug content. The bilayer tablets of the present work provide dual release rates of the individual 
components wherein, an accurate dose of individual active ingredient is delivered. The process involves reduced manufacturing steps and 
manufacturing time making it a cost effective and a physically and chemically stable dosage form. 
Keywords: Indapamide; Telmisartan; Hypertension 
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DEVELOPMENT AND VALIDATION OF RP- HPLC ANALYTICAL ASSAY METHOD FOR 
EZETIMIBE AND SIMVASTATIN TABLET 
ARTI NANDWANA*, GURDEEP SINGH, ISHAB KUMAR, NEETESH K JAIN, MAHESH GUPTA 




The aim of the present work was to develop and validate a  of simple, accurate, precise and highly selective reverse phase high performance liquid 
chromatographic (RP-HPLC) method for simultaneously estimation of ezetimibe and simvastatin in combined pharmaceutical dosage form. The 
separation was achieved by chromosil C18, column having 250x4.6mm internal diameter and methanol: acetonitrile: 0.1% orthophosphoric acid in 
the ratio of 75:25:05(V/V/V) as a mobile phase at a flow rate of 0.5-1.5ml/min for optimum separation .detection was carried out using a UV- vis 
detector at 243nm.The mean retention time of simvastatin and ezetimibe was found to be 6.10 and 3.35 respectively. Determination of the different 
analytical parameter such as linearity, precision, accuracy, and specificity limit Of detection (LOD) and limit of quantification (LOQ) was done. 
Keywords: Ezetimibe; Simvastatin; Validation; RP-HPLC; Method development 
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G-TECHNOLOGY: AN INNOVATIVE METHOD FOR DRUG DELIVERY TO THE BRAIN 
MONIKA MAAN* 




When of it comes to treatment brain-related illnesses, the central nervous system (CNS) is one of the most difficult organs to reach. The reason 
behind it the various barriers such as blood brain barrier, blood cerebrospinal fluid barrier and blood tumor barrier present in central nervous 
system. This unmet medical market is very large as it affects two billion people worldwide. The large interest from top-tier pharmaceutical and 
biotechnological companies indicates the difficulty of transporting drugs across the blood brain barrier, with the help of 2B3 platform technologies. 
Where the blood-brain barrier blocks many modern medicines, 2B3 is enabling successful development of new treatments for patients with 
devastating brain diseases. 2B3technology platforms open new gateways to treat devastating brain disorders like brain tumors, Alzheimer’s disease 
and lysosomal storage diseases by combining with established and marketed drugs. G-Technology® 2B3provides the safest proprietary brain drug 
delivery platform. This G-Technology is the core platform and stands for liposomes coated with glutathione-conjugated PEG to mediate safe 
targeting and enhance the delivery of drugs to the brain. Glutathione uniquely minimizes common risks like adverse immunological reactions or 
interference with life-essential physiological pathways. 
 
 
The plasma level of the liposomal drug was greatly enhanced (500 times compared to the free drug), while the liposomal formulation did reduce the 
dose-limiting toxicity associated with the free drug. Using a brain microdialysis technique, the free drug in the extracellular fluid of the brain was 
measured, which indicates that the drug was actually released from the intravenously administered liposomes. This approach is unique in that it 
does not require drug modification and at the same time gives rise to metabolic protection during transport and increased bioavailability at the 
target site.  
Keywords: Liposomes; Microdialysis technique; Blood-brain barrier; G-Technology 
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EXTRACTION AND IDENTIFICATION OF BAKUCHIOL FROM PSORALEA CORYLIFOLIA LEAVES 
BY EXTRACTION PROCESS 
PARAS BODANA*, GIRVAR KELKAR, SHAILENDRA MANGLAVAT, RITA BHARDWAJ, ARUN GUPTA      




Psoralea corylifolia Linn be cultivated garden center and two types of immatured seeds were composed in beginning of December and honestly 
extracted with toluene.Matured sheds be collected in beginning of January and stored in a porous cotton bag at room temp. From the stored seeds, 
50-100 gm of the seeds was regularly extracted at an interval of 30 days for six months and last lot of the seeds was extracted at the end of one year. 
The chemistry medicinal properties and pharmacological activities of Psoralea corylifolica Linn were discussed. Development of commercial 
method for extraction of bakuchiol and its estimation from seeds is described. Effect of bakuchiol yield with maturity of seeds studied. Abnormal 
variation in yield of bakuchiol with increasing age of seeds had been observed.  This abnormality was found due to abnormal formation of bakuchiol 
derivatives during long storage of the seed-extract. Derivatives were isolated and identified as 6,7-epoxybakuchiol, 7-hydroxybakuchiol, 6-
hydroxybakuchiol.  
Keywords: Psoralea corylifolia; Cultivation; Extraction; Bakuchiol; 6,7-epoxybakuchiol. 
  
Vol 11, Issue 7, 2018 
 
Online - 2455-3891 
 Print - 0974-2441 
 
26 
Proceedings: Global Scenario in Pharmaceutical Industrial and Academic Research (Intellectual Property: Creation & Protection) GSPIAR 








FORMULATION AND EVALUATION OF HERBAL LIPSTICK  
NUTAN MIMROT GOTHWAL*, REVATHI A. GUPTA, RINKU VERMA 




Lipstick is a cosmetic product containing pigments, oils, waxes, and emollients that apply color, texture, and protection to the lips. The aim of 
present study was to formulate herbal lipstick using herbs because a use of herbs in cosmetic application has increasing exponentially during 
recent years.  The objectives of this study involves the preparation and evaluation of herbal lipstick containing Acacia concinna, Citrus sinesis, 
beeswax, coconut oil, beet root, vanilla essence and vitamin E capsules use as preservative and Evaluation parameters such as melting point,  
breaking point,  thixotropy character,  force of application and surface anomalies were performed. The results showed that the formulation have 
better stability and having minimal or no side effects. 
 Keywords: Lipstick; Acacia concinna; Citrus sinesis; Beeswax. 
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PREPARATIONS AND EVALUATIONS OF HERBAL FOOT CREAM USING HERBAL 
INGREDIENTS 
RINKU VERMA*, REVATHI A. GUPTA, NUTAN MIMROT GOTHWAL 
 Institute of pharmacy, Dr. APJ Abdul Kalam University, Madhya Pradesh, Indore 
Email: rinku.cip@gmail.com  
 
Abstract 
Ultimate goal of this formulation is healthy and beautiful skin. The foot creaks and makes heal good in appearance and smooth. Among the available 
formulation we used cream for these preparations. The objective of this formulation was to formulate and evaluate Herbal foot cream. The 
chandras for wound healing activity, glycerine for moisture, suhaga for antifungal activity and haldi (turmeric) for antiseptic property, camphor for 
cooling sences and for fragences, and coconut oil and paraffin mom used for base material. In this preparation chandras used 1%, glycerin 2%, haldi 
& suhaga 0.5%, paraffin mom 1.5%, camphor 0.5%, coconut oil 4 %., pH of formulation is netural,which is suitable for skin. For the cream 
evaluation test we evaluated the foot cream by the different parameters like nature of cream, colour, stability test, pH test, irritant test, and other 
parameters. All parameters are found to be in range of a ideal cream preparation which are compared with referred articles like pH was found to be 
in range of natural which is good for skin and no grittiness is found and formulation show good spredibility. 
Keywords: Chandras; Glycerin; Camphor; Haldi; Suhaga; Coconut oil.  
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FORMULATION AND EVALUATION OF HERBAL HAIR OIL FOR HAIR GROWTH 
RINKU VERMA*, REVATHI A GUPTA 
Institute of Pharmacy, Dr. APJ Abdul Kalam University, Madhya Pradesh, Indore 
Email: rinku.cip@gmail.com  
 
Abstract 
Hair is the one of the vital part of our body and it influences the overall appearance of the person. Hair care products are defined as those 
formulations which are used for cleansing, modifying the texture of hair, changing of the color, giving life to the stressed hair, providing 
nourishment to the hair and giving the healthy appearance to the hair . Hair oil those contains herbal drugs are called as hair tonics .The nature of 
oil is non sticky and addition of perfumes enhances the fragrance and overall improves its popularity. Proper application of hair oil gives luster to 
hair, softening the hair, gives flowness to hair and more important gives cooling effect to brain.The main objective of the research was to formulate 
and evaluate Herbal hair oil using Coconut Oil, Aloevera, Black Caraway , Vitamin E for better  growth of hair. The formulated herbal hair oil was 
successfully evaluated using different standard parameters including sensitivity test, Acid value,saponification value, ph, specific gravity.Excellent 
results of hair growth were seen in formulation prepared by boiling method of oils preparation technique.  
Keywords: Coconut Oil; Aloevera; Black Caraway; Vitamin E. 
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RADIOPHARMACEUTICALS APPLICATIONS IN PHARMACY – A REVIEW OF CURRENT 
APPROACHES 
RINKU VERMA*, REVATHI A GUPTA, MOHD. FAAROOQ KHAN 




The compounds or substance which emit radiation and which are used in medicine area called radiopharmaceuticals. Radiopharmaceuticals 
preparations are the preparations containing one or more radionuclides. A radiopharmaceutical is a preparation intended for in-vivo use that 
contains a radionuclide in the form of a simple salt or a complex.  It may exist as a solid, liquid, gas or a pseudo gas. The chemical and physical 
identity and a form of a radiopharmaceutical are very important because in each case, once administered the radiopharmaceutical is intended to 
target certain tissues, binding sites, biochemical pathways. A radiopharmaceutical can be used for either diagnostic or therapeutic purposes 
depending on its specific physicochemical and radiation properties. The characteristic of radioactive decay is what makes radioisotopes useful in 
their medical applications; however, different applications will take advantage of radioactive emissions in different ways. Radioactive materials are 
regularly used to treat medical conditions, diagnosis pathology, visualize and measure physiological functions, and localize structures and 
pathways. This review describes both the therapeutic as well as diagnostic uses of radiopharmaceuticals. 
Keywords: Radiopharmaceuticals; Radioisotopes; Radioactive decay 
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LEGISLATION COVERING INTELLECTUAL PROPERTY RIGHTS IN PHARMACEUTICAL 
SCIENCE: A REVIEW 
 
SHELENDRA KUMAR MANGLAVAT*, PARAS BODANA, GIRVAR SINGH KELKAR, ARUN KUMAR GUPTA 
Faculty of Pharmacy, Dr. A.P.J. Abdul Kalam University, Indore, Indore Bypass Road, Arandia Village, Post Jhalaria, Mangliya, Indore, 




Intellectual Property Right (IPR) is a right given over a design, innovation, creation, ideas based on their public enthusiasm in status of property. 
IPR covered Patents, Trademarks, Copyrights, Industrial Design, Inventions and TRIPS. The IPR must possess utility for the grant of patent. In 
Pharmaceutical Industries IPR protects many principals covering such as Pricing of medicine and R&D. Research & Development gathering new 
innovations which type used drugs, develop and discovered new drugs, design of new drugs. The IPR covered legislation through licences and 
layout design of pharmaceutical industries. IPR satisfies the criterion of global innovation, non-obviousness, and industrial or commercial 
application. Its comprehensive clear understanding of intellectual property rights is precondition for better Identification, Planning, Rendering and 
there by protection of inspiration. 
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A REVIEW: DEVELOPMENT AND EVALUATION OF POLY HERBAL MOSQUITO REPELLENT 
DEEPAK KUMAR GUPTA*, MANOHAR CHOUHAN, REVATHI A. GUPTA, ARUN K. GUPTA 
Dr. APJ Abdul Kalam University, Indore (M.P) 
Email: deepak_gupta20072008@yahoo.com  
 
Abstract 
A large number of essential oil and medicinal herbs has been reported as a antibacterial, antiviral, antifungal, insecticides and one of which is their 
property to repel the mosquitoes. An essential oil is a concentrated hydrophobic liquid containing volatile aroma compounds from plants. And their 
repellent activity has been linked to the presence of sesquiterpenes and    monoterpenes.In this time herbal formulations have growing demand in 
the world market.  The poly herbal mosquito repellents are designed as topical preparations that are able to protect the user or environment from 
harmful insects, such as mosquitoes which transmit diseases through their bite. The proposed methodology might be providing better or similar 
compared to the synthetic repellents. The present formulation help to reduce harmful side effects and it is a convenient formulation for children as 
well as adults. The essential oil and plants extract has been reported in the literature having good mosquito repellent activity. 
Keywords: Mosquito repellent; Polyherbal cream; Polyherbal extract; Essential oil; Evaluation parameter 
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UPLC ULTRA POWER LIQUID CHROMATOGRAPHY: ADVANCE TECHNOLOGY USED IN 
INDUSTRY FOR ANALYTICAL ESTIMATION 
RITA BHARDWAJ*, GIRVAR KELKAR, STEFFY MARY CHANDI, PARAS BODANA, REVATHI A. GUPTA      




Separation science is revolutionized among the introduction of Ultra-Performance Liquid Chromatography UPLC Technology. Momentous advance 
in instrumentation and column technology were ready to accomplish spectacular increases within resolution, speed and sensitivity in liquid 
chromatography. A holistic loom involving simultaneous innovations within constituent part technology and instrument design are endeavored 
headed designed for meet furthermore overcome the challenges of the analytical laboratory. UPLC Technology facilitates improvements of 
resolution, sensitivity and speed to be achieved, without compromise. This technology briefing is premeditated near provide with innovative, 
accessible furthermore prospective UPLC user the aptitude to comprehend how UPLC Technology installation, how to exist successful among it, and 
how it can provide impactful results within their organization. The Acuity UPLC Sample Manager is considered near minimize the distance between 
the injector and column inlet in order toward minimize band spreading. The column separates the sample band addicted toward creature analyte 
band. 
Keywords: UPLC; Column technology; Separation; Analyte; Injector 
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EVALUATION AND FORMULATION OF FLOATING EFFERVESCENT TABLETS OF RAMIPRIL 
MOHD.FAAROOQ KHAN1*, VIMUKHTA SHARMA2, UMESH ATNERIYA2 
1Institute of pharmacy, Dr.APJ Abdul Kalam University,Indore Madhya Pradesh,India.2,3BM College of Pharmaceutical Education and 
Research. Email: mohd.faarooqkhan@yahoo.com 
  
Abstract 
Ramipril is antihypertensive prodrug which belongs to the category  angiotensin-converting enzyme (ACE) inhibitor class. In Liver it is metabolized 
to ramiprilat in the liver. Ramiprilat is a potent, competitive inhibitor of ACE. This research is designed to develop a dosage form which retains in 
the stomach for longer time and the release of which is prolonged.  Effervescent Floating tablets containing Ramipril were prepared in different 
batches i.e. F1 to F9 by direct compression technique using varying concentrations of different grades of polymer with Sodium bicarbonate and 
citric acid. Fomulation of effervescent tablets  were evaluated by drug characterization and identification by Physical appearance,Melting point, 
FTIR which identified the purity of drug. Preformulation studies was  done by preparation of calibration curve. Post compression evaluation was 
done by Drug content, Buoyancy lag time (BLT), Total floating time, Drug release study,in-vitro drug release. In vitro release studies of F1 to F9 
formulations of Ramipril were carried out in the dissolution test apparatus (USP Type II). It is, thus concluded that effervescent floating tablet 
containing Ramipril (F9 formulation) gave slow and complete drug release spread over 20 hours. Thus F9 formulation was said to be optimized 
formulation.  Stability study and others thickness, diameter,hardness, friability and weight of variation were also done. The spectrum thus obtained 
was compared with reference spectrum of Ramipril. The FT-IR spectra for pure drug was obtained by power diffuse reflectance on a FT-IR 
spectrophotometer in the wave number region of 4000-400 cm-1. The UV spectroscopy of ramipril exhibited absorbance maxima (λmax) at 231 nm 
in 6.8 pH buffer. The results obtained may be considered as tools for the manufacturer of standard formulation with great efficacy. 
Keywords: Ramipril; Effervescent; Floating; Tablet; FDDS; HPMC 
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PHARMACOPHORE STUDY OF IMIDAZOQUINOLINE DERIVATIVES AS DPP-IV INHIBITORS  
STEFFY MARY CHANDY1*, SUDHA VENGURLEKAR2, S. C. CHATURVEDI2 
1IOP, Dr.  APJ Abdul Kalam University, Indore, (M. P.).2Sri Aurobindo Institute of Pharmacy, Indore, (M.P.) 
Email: steffymarychandy09@gmail.com  
 
Abstract 
Type II diabetes is establishing itself as an epidemic of the 21st century and is a severe and increasingly prevalent disease. Currently used 
antidiabetics are associated with a number of side effects which are known to decrease quality of life for type II diabetes patients. Under these 
circumstances, intensive efforts have been made to find better and safer oral drugs for type II diabetes. Inhibition of DPP-IV is emerging as a 
promising approach for treatment of type II diabetes with low risk of hypoglycemia. The present study successfully applied pharmacophore 
mapping, and molecular docking analysis to characterize a set of synthesized DPP-IV inhibitors. Imidazoquinoline derivatives were subjected to 
pharmacophore study using SYBYL X 2.1.1 software. The pharmacophore models were derived using GALAHAD module of SYBYL X 2.1.1 software. 
The optimal pharmacophore model contains nine pharmacophore features. The pharmacophore model provided enough information to understand 
the structural features influencing DPP-IV inhibitory activity. The information obtained by the study provides a methodology for predicting the 
affinity of imidazoquinoline derivatives for guiding structural design of novel potent DPP-IV inhibitors. The study will serve as a useful guideline for 
designing the novel compounds with significant DPP-IV inhibitory activity. 
Keywords: Imidazoquinoline; Pharmacophore; Antidiabetics; DPP-IV inhibitors 
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FORMULATION AND EVALUATION OF FLOATING MICROSPHERES CONTAINING LEVODOPA 
AND CARBIDOPA 
AJIT KUMAR VARMA*, ARUN KUMAR GUPTA, PIUSH KHARE 
Faculty of Pharmacy, Dr. A.P.J. Abdul Kalam University, Indore - 452016, M P (India). 
Email: Ajitpharma786@gmail.com  
 
Abstract 
The main objective of work to develop  long acting sustained release floating microballons of levodopa and carbidopa by emulsion-solvent 
evaporation technique for the treatment of Parkinson,s disorder..All current levodopa products are formulated in combination with aromatic amino 
acid decorboxylase inhibitors such as benserazide to prevent the peripheral metabolism of levodopa.In the present research work was to produce 
floating microspheres of carbidopa and levodopa to enhance their efficacy by increasing their gastric retention time which is major technique to 
improve efficacy of narrow absorption window drugs, and its improved bioavailability.The effect of various formulation were evaluated and 
process variable on the particle size ,in vitro floating behavior, percentage yield and in vitro drug release were studies.Further,the microspheres 
could also be compressed in to tablets, filled in to capsule or formulated in to oral suspension for reconstitution. 
Keywords: HPMC K15M; EC; Emulsion-solvent evaporation technique; Parkinson,s disorder.  
 
  
Vol 11, Issue 7, 2018 
 
Online - 2455-3891 
 Print - 0974-2441 
 
36 
Proceedings: Global Scenario in Pharmaceutical Industrial and Academic Research (Intellectual Property: Creation & Protection) GSPIAR 








EVALUATION OF SYNERGISTIC EFFECT OF CORIANDRUM SATIVUM SEED EXTRACT AND 
ACACIA NILOTICA LEAF EXTRACT AS TREATMENT OF OBESITY 
NEETU PANCHOLI*, RAGHVENDRA DUBEY 




Coriandrum sativum (Coriander) has been documented as a traditional treatment for cholesterol and diabetes patients. In the present study, 
coriander seeds incorporated into diet and the effect of the administration of coriander seeds on the metabolism of lipids was studied in rats, fed 
with high fat diet and added cholesterol. Coriandrum sativum (common name: Coriander) belonging to family Umbelliferae, is an herb that is widely 
cultivated in India and possessing the nutritional as well as medicinal properties are among the most commonly used spices. The first medicinal 
uses of the plant were reported by the ancient Egyptians. Both the leaves and seeds of the plant are used for medicinal purpose. Coriander contains 
many active principles, primarily monoterpenes, α-pinene, limpnene, γ-terpinene, pcymene, borneol, citronellol, camphor, geraniol, coriandrin, 
dihydrocoriandrin, coriandrons A-E, flavonoids and essential oils. Coriandrum sativum has been reported to have several pharmacological effects 
such as antifertility, antihyperglycemic, antihyperlipidemic, antioxidant, anti proliferative, hypotensive and digestive stimulant. Coriander is also 
used in detox diet. It helps to remove toxic mineral residue such as mercury and lead, and excrete them in the urine or faeces. 
Keywords: Coriandrum sativum; Antihyperglycemic; Antihyperlipidemic; Antioxidant; Anti proliferative 
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PHARMACEUTICAL INDUSTRY AND ACADEMIACOLLABORATION: APPROACHES TO 
RESEARCH AND INNOVATIONS 
GIRVAR SINGH KELKAR*, PARAS BODANA, SHALENDRA KUMAR MANGLAWAT, STEFFY MARY CHANDY, RITA 
BHARDWAJ, REVATHI A GUPTA. 




The pharmaceutical industry needs to consider new approaches to tackle the R&D output challenge it is currently experiencing. One approach to 
meet these challenges is to promote innovation by joining forces with partners such as biotech companies, other pharmaceutical companies, and 
academia. Such open innovation concepts are now gaining increasing importance. Whereas classical in‐licensing or mergers and acquisitions 
(M&As) have been traditionally pursued, early research collaborations aiming to enrich the idea pool and de‐risk early research projects are 
gaining interest. Novel models are arising, such as crowd sourcing initiatives or concepts based on the sharing of tools and assets. These 
endeavours are matched with a rise in interest in academia to contribute to drug discovery, resulting in the establishment of academic screening 
centers or open access initiatives. Furthermore, novel approaches to share tools and assets will be described such as the probe program of the 
Structural Genomics Consortium. Besides innovative models, the chapter will highlight requirements within the industry to ensure the uptake and 
further development of innovative ideas. 
Keyword: Open innovation; Research collaborations; Structural Genomics Consortium; Innovative models. 
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SOLVENT DEPOSITION SYSTEM AND FORMULATION DEVELOPMENT OF RAPID 
DISINTEGRATING PIROXICAM TABLET USING SIMPLEX LATTICE DESIGN 
DEEPIKA BAIRAGEE*, PRIYANKA NAGAR, RAJU CHOUKSE, ARUN K GUPTA 




The objective of the present study is to develop and evaluate rapid disintegrating formulation of Piroxicam tablet using simplex lattice design. 
Solvent disposition system is used to increases the solubility of poorly water soluble Piroxicam. Simplex lattice design is used for the selection and 
optimization of disintegrant concentration, types of filler that has pronounced effect on tablet properties, disintegrating time and drug release 
profile. The blend was examined for bulk density, tapped density, Hausner’s ratio, angle of repose and compressibility index. Different formulations 
from F1 to F7 was prepared and the prepared tablet was evaluated for hardness, friability, drug content, in-vitro drug release and the results were 
found satisfactory.  Stability study has been carried out for selected formulations (F4, F5 and F6) and found that the formulation is stable enough at 
different temperature conditions (40˚C, 50˚C and 60˚C). Half life of RDT of Piroxicam was found more with decreasing temperature (40˚C) whereas 
increasing temperature the half life decreases (50 and 60˚C). Shelf life of RDT of Piroxicam more with decreasing temperature  (40˚C) whereas 
increasing temperature the half life decreases (50˚ and 60˚C). Hence above study concluded that the RDT of Piroxicam decomposition under 
elevated temperature. 
Keywords:  Piroxicam; Rapid disintegrating tablet; In-vitro drug release; Half life; Stability study   
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FORMULATION AND EVALUATION OF POLYHHERBAL ANTIFUNGAL FOOT CREAM BY USING 
OCIMUM SANCTUM LINN, CURCUMA LONGA LINN AND AZADIRACHTA INDICA 
DEEPIKA BAIRAGEE*, DEVENDRA BAIRAGEE, NEETU CHOUDHARY, SWETA KULKARNI 




The main objective of our present research work was to develop a novel formulation consisting of combination of Ocimum sanctum Linn, Curcuma 
longa Linn and Azadirachta indica for the treatment of fungal infection of foot. Also to formulate effective, stable polyherbal antifungal foot cream 
and evaluate its physical and antifungal activity.  The ethanolic extract was prepared by using maceration method. The cream base was prepared 
and the formulation of foot cream was done by incoperating the extract in the base by levigation method. After the completion of formulation it was 
evaluated for its physicochemical parameters like colour, odour, pH, spreadability, extrudability, consistency, diffusion study, solubility, wash 
ability. Also the formulation was evaluated for its stability at different temperature which shows no change in the irritancy, spreadablility, 
extrudability and diffusion study.  
Keywords:  Spredability; Maceration; Levigation; Antifungal; Extrudability; Azadirachta indica 
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FORMULATION AND EVALUATION OF HERBAL SYRUP FOR THE TREATMENT OF COUGH  
 
ABHISHEK DWIVEDI1*, SUMEET DWIVEDI2, SHAILESH GUPTA 
1Pharmacy Department, RKDF University, Bhopal, (M.P.), India.2Swami Vivekanand College of Pharmacy, Indore, (M.P.), 




Cough is a very common problem associated due to pollution and other causes. The present paper deals with the formulation and evaluation of 
herbal cough syrup. Five different batches of formulation was prepared  using aqueous extract of Ocimum sanctum, Eugenia carophyllus, Foeniculam 
vulgare, Piper lomgum, piper nigrum, Ficus relegiosa. The prepared formulated was evaluated and it was found that the formulation code F3 is 
effective in the treatment of cough.  
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TRADITIONAL PHYTOTHERAPY OF MALWA REGION OF MADHYA PRADESH: IN 
REFERENCE TO THE TREATMENT OF VIRAL HEPATITIS  
MOHIT CHATURVEDI1*, RAJU CHOUKSE1, SUMEET DWIVEDI2 
1Faculty of Pharmacy, Dr. APJ Abdul Kalam University, Indore, Madhya Pradesh, India.2Swami Vivekanand College of Pharmacy, 




WHO has already recognized the contribution of traditional health care in tribal communities; in the present work authors have collected 28 plant 
species from different study sites of Malwa region of Madhya pradesh. These species contain valuable chemical substances and are useful to cure 
viral hepatitis. During the course of present investigation attempt was made to flourish the status and conservation strategies of the plant species 
and among 28 plant species it has been found that 04 species are endangered, 08 species are critically endangered, 05 species are vulnerable, and 
rest are rare and common in occurrence in the study area and the method are mentioned by the ethnic group to conserve these plant species. 
However, different types of strategies are require to adopted such as in-situ conservation, ex-situ conservation and traditional conservation to 
conserve the plants which are vulnerable and endangered. 
Keywords:  Phytotherapy; Viral Hepatitis; Malwa region 
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RATIONAL DESIGNING IN-SILICO SCREENING AND IN-VITRO EVALUATION OF HETEROARYL 
ACETIC ACID ANALOGS AS ALDOSE REDUCTASE INHIBITOR 
ARUN KUMAR GUPTA, PRIYANKA NAGAR 




NADPH oxidoreductase, play an important role in the many pathogenesis such as neuropathy, nephropathy and retinopathy in diabetic patient. 
Various scaffolds have been explored to overcome such complications. Yet most of them have been retreated since undertaking clinical assays, 
because of low efficacy, unfavorable side effects, or toxicity. Thus, there is an urgent need to develop new NADPH oxidoreductase inhibitors (aldose 
reductase inhibitors), which may alter the physicochemical properties and enhanced the bioavailability as well as devote from the adverse effects. 
On the basis of extensive literature study set of compounds heteroaryl acetic acid analogs were rationally designed. These compounds were 
subjected to in-silico study using docking algorithm. Docking studies of these compounds revealed that the heteroaryl moiety deeply influenced the 
key p-p stacking while acetic acid group contributed in hydrogen bond interactions with Tyr 48, His110 and Trp 111. The phenyl ring of scaffold 
showed - sticking with Trp111, while benzimidazole showed - sticking with Try20. The structural insights obtained from the docking study 












Key Words: Aldose Reductase Inhibitors; Heteroaryl acetic acid analogs; Diabetic complications 
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DESIGN, DEVELOPMENT AND CHARACTERIZATION OF HERBAL CREAM FOR THE 
TREATMENT OF VAGINAL INFECTION 
SHWETA SHRIWAS* AND RAJU CHOUKSE  




Vaginal infections (vaginitis, Candidal vaginitis, or Candidal vulvovaginitis ) are very common gynecological disorders caused by yeast. Over 90% of 
vaginal yeast infections are caused by the species known as Candida albicans. The present study was aimed to formulate and evaluate herbal cream 
formulation of Plumeria pudia leaf extract for the local treatment of vulvovaginal candidiasis. Herbal cream formulation was prepared using hydro-
alcoholic extract having different polymers as gelling agent in varying concentrations. The formulated creams were evaluated for physical 
appearance, pH, viscosity, extrudability, spreadability, antifungal activity and in-vitro drug release study. Stability studies were carried out as per 
ICH guidelines for 3 months at different temperatures and humidity. It is observed that the cream formulation (F5) shows good antifungal activity 
and it was found to be best and stable among the prepared batches. It was inferred from the results that all the performed experiments confirm the 
applicability of herbal intravaginal cream for the local treatment of vulvovaginal candidiasis. 
Keywords: Herbal cream; Plumeria pudica; Vaginal infection 
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FORMULATION AND EVALUATION OF TOPICAL ANALGESIC HERBAL GEL CONTAINING 
ROOT EXTRACT OF PLUMERIA PUDICA LINN 
 SUMAN GEHLOT, *SUMEET DWIVEDI 




Analgesic herbs are natural pain reliever that reduce or eliminate pain. These pain relief herbs are available in the market in analgesic topical forms 
like essential oil and analgesic cream- that can be directly applied at the pain sites- as well as in form of capsules, tea and tinctures for pain relief. 
The present paper deals with the formulation and evaluation of topical analgesic gel containing hydroalcoholic extract of Plumeria pudica (roots). 
The topical gel was prepared and was further investigated for its analgesic activity using standard diclofenac gel.  
Keywords: Analgesic activity; Topical gel; Plumeria pudica  
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TRADITIONAL HERBAL KNOWLEDGE AND CONSERVATION OF BIODIVERSITY FOR 
SUSTAINABLE LIVELIHOODS BY TRIBAL AND NON-TRIBAL COMMUNITIES IN CENTRAL 
INDIA 
SUMEET DWIVEDI,* S.K. SHRIVASTAVA 




Human population i.e., tribal and non-tribal communities have been dependent on plants from ancient. This has enabled them to evolve a unique 
system of knowledge on the utilization and conservation of plant resources. Medicinal properties of herbs have been recognized and utilized by 
tribal and non-tribal communities for thousands of years. They possess a great deal of knowledge about medicinal plants and medicines for 
curing diseases. The farming practices of tribal and non-tribal people are truly sustainable in many ways. Their subsistence life style, local diet 
habits and dependence on rain fed irrigation have influenced them to cultivate and conserve the traditional cultivars or land races.  During the 
study in various study sites of Central India it was observed that they have their own way of sustainable livelihoods and methods to conserve and 
use the plants traditionally. The present papers deals with all these aspects of tribal and non-tribal communities. 
Keywords: Traditional; Tribal’s Communities 
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FORMULATION AND EVALUATION OF BILAYER TABLETS OF METFORMIN AND 
ROSUVASTATIN 
NEETU CHOUDHARY*, DEEPIKA BAIRAGEE, SWETA KULKARNI, RAJU CHOUKSE 




It was found that with the designing of bilayer tablet of Metformin HCl and Rosuvastatin Ca+2 in which Rosuvastatin Ca+2 in one layer releases 
instantly due to the presence of Cros Carmelose sodium as superdisintergrating agent and Metformin HCl follow the release slowly by HPMC high 
molecular weight matrix in the order to match with the innovator product. Finally it was concluded that Bilayer tablet of Metformin HCl and 
Rosuvastatin Ca+2 can be prepared by using optimized level of high viscosity of HPMC in sustained release layer and cros carmelose sodium in 
instant release layer.Three main excipients were selected for the purpose of improving desired characterization of granules and tablets such as 
solvent used, Methocel (K 4M and K 100M), and Lubricant. Eight batches (F1 to F8) were prepared with different excipients in varied concentration 
along with the The simulation of the drug release profile of developed product with innovetor’s product was obtained in batch F8 by manipulating 
the process in which Methocel K100M was added in the formulation in two parts.  F8 good flow property of granules and the desired drug release 
profile as similar to innovator’s product. The project work was mainly aimed to design the formulation of immediate release tablets of Rosuvastatin. 
In batch R1 to R3 SSG was used in increased manner shows decrease in the disintegration time and in batch R4 to R6 Crospovidon XL was used in 
increased manner shows improve in disintegration time and better release profile in R6.  




Vol 11, Issue 7, 2018 
 
Online - 2455-3891 
 Print - 0974-2441 
 
47 
Proceedings: Global Scenario in Pharmaceutical Industrial and Academic Research (Intellectual Property: Creation & Protection) GSPIAR 








DEVELOPMENT OF NOVEL CARRIER SYSTEM FOR EFFECTIVE TREATMENT OF DIABETES 
WITH HERBAL PLANT EXTRACTS  
NEELIMA SALVI1,2*, G.P. CHOUDHARY1 




Diabetes cannot be cured completely, Incidence of diabetes mellitus increasing day by day. Synthetic drugs which are used for the treatment of 
diabetes have many side effects and frequency of dosing is more. To overcome such problems novel carrier system has been chose. Herbal extracts 
have been widely accepted as the potential medicines with less side effects as compared to synthetic drug molecules. Biodegradable polymers are 
having wide use for the preparation of vesicular system to control the drug release pattern of drugs. “Polymeric microparticles” considered as novel 
carrier technique to control the release of herbal plant extracts from vesicular system. Extraction of crude drug (Murraya koenigii) done with 
successive solvent extraction method by using different solvents like Petroleum ether, ethyl acetate, chloroform, methanol, and ethanol. In 
phytochemical screening we found different constituents of the plant but leaf extract of murraya koenigii have hypoglycemic effect on 
streptozotocin induced diabetes in rats. Polymeric microparticles formulated with hot melt method and emulsification method. After 
characterization the microparticles which are made from hot melt method shows good results of drug release and entrapment efficiency. In the 
current research work micoparticles has been developed of chitosan employed to enhance the drug release. Polymeric micopartcles were 
characterized and evaluated for antidiabetic activity. Murraya koenigii decrease the blood glucose level in albino rats. 
 Keywords: Diabetes Mellitus;  Crude Drug; Micoparticles 
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PROCESS VALIDATION OF ORAL NON STERIODAL ANTI INFLAMMATORY DRUG –IBUPROFEN 
SWETA KULKARNI*, BHAGYASHREE PATIL, DEEPIKA BAIRAGEE, NEETU CHOUDHARY 




The purpose of this research was to provide documented evidence that the manufacturing process of Ibuprofen 400 mg coated tablet meets the 
predefined control parameters. This involves in-process monitoring of critical processing steps and end product testing of current production can 
document evidence to show that the manufacturing process is in a state of control. The objective of the study is to form a basis for written 
procedures for production and process control which are designed to assure that the drug Ibuprofen 400 mg coated tablet have the identity, 
strength, quality and purity they purport of are represented to possess. The critical parameters identified and evaluated were dry mixing, blending, 
preparation of granulating agent and compression .These parameters were evaluated by challenging its lower & upper release specification as per 
validation master plan. Three initial process validation batches of same size, method, equipment & validation criteria was taken. Results obtained 
with  process validation data provides high degree of assurance that manufacturing process produces product meeting its predetermined 
specifications and quality attributes, thereby decreasing the need for processing and customer complaints. It also provides documented evidence 
for the operation sequence of manufacturing process and to determine the critical parameters and variables in the process of manufacturing of the 
tablets.  
Keywords: Ibuprofen; Process Validation; Critical parameters; Validation Master plan 
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NOVEL TECHNOLOGY FOR TRANSDERMAL DRUG DELIVERY SYSTEMS BY SONOPHORESIS 
RITA BHARDWAJ*, SHIKHA SHRIVASTAV, GIRVAR KELKAR, ATUL PAL, REVATHI A  GUPTA      
Institute of Pharmacy, Dr. A.P.J. Abdul Kalam University Indore Bypass Road, Arandia Village, Post  Jhalaria, Indore, Madhya Pradesh  
 Email: rita.bhardwaj06@gmail.com 
 
Abstract 
Transdermal drug delivery is an alternative approach in comparison with conventional oral drug delivery systems. However, the stratum corneum, 
the outermost layer of the skin, acts as a barrier that limits the penetration of substances through the skin.Applications of ultrasound to the skin 
increase permeability (sonophoresis) and facilitates the delivery of a variety of substances addicted to and through the skin.Generation of 
ultrasound and mechanism of sonophoresis with particular emphasis cavitation, convective transport, and mechanical effects also included. 
Sonophoresis, namely transdermal drug delivery and transdermal monitoring. Low frequency sonophoresis or ultrasound is defined as 
sonophoresis or ultrasound at a frequency that is less than 2.5 MHz, more typically less than 1 MHz, more preferably in the range of 20 to 100 kHz. . 
It reduces pain, bio hazardous waste, and risk of infection. Most importantly, needle-free drug delivery generally increases patient compliance. The 
present paper highlights the recent advancements in the field of sonophoresis, its mechanism and applications. 
Keywords: Sonophoresis; Epidermis; Ultrasound; Needle-Free Drug delivery system. 
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A PROCESS VALIDATION OF NEBIVOLOL HYDROCHLORIDE TABLETS 
JEEVAN PATEL*, SHIKHA SHRIVASTAVA, REVATHI A GUPTA 




The objective of the study is to validate written procedures for production and process control which are employed to assure that the drug 
Nebivolol Hydrochloride tablets 5 mg have the identity, strength, quality and purity they purport of are represented to possess. It is done by 
checking and controlling the critical parameter in process and by evaluation of final product. The process validation is done as per specifications. All 
processing parameters are compared with the standard specifications, the manufacturing process parameters sieve integrity, appearance, bulk and 
tapped density, blend uniformity and assay, weight variation, hardness and thickness, Friability, disintegration time, packaging parameters &the 
results showed that the all parameters are within the limits. It was concluded that the process validation data of Nebivolol Hydrochloride tablets 5 
mg showed that there was no significant variation between parameters of different batches. Thus the process is validated. 
Keywords: Nebivolol Hydrochloride; Lactose monohydrate; Maize starch; Croscarmellose sodium; HPMC; MCC; Silica (colloidal anhydrous); 
Magnesium stearate. 
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ALDOSE REDUCTASE INHIBITORY POTENTIAL OF AQUEOUS AND METHANOLIC EXTRACT 
OF SEEDS OF ABELMOSCHUS ESCULENTUS LINN. 
KUSHAGRA DUBEY1*, RAGHVENDRA DUBEY2, ARUN GUPTA2 




To study the inhibitory effect of aqueous and methanolic extract of seeds of Abelmoschus Eesculentus Linn. on aldose reductase of goat lens. Goat 
lens were isolated from goat eye and enzyme preparation was done by the method of Hayman and Kinoshita in which homogenate was prepared 
and centrifuged. Clear supernatant was obtained which was used for aldose reductase inhibitory assay. From the result it was observed that both 
the extracts show significant aldose reductase inhibitory activity but methanolic extract is more potent inhibitor then aqueous extract and IC50 
value of both the extract was found to be 36 µg/ml ± 1.10 and 98 µg/ml ± 1.62 respectively. Quercetin was used as standard. Thus it was concluded 
that methanolic extract of seeds of Abelmoschus Esculentus exhibit more potent inhibitory effect on aldose reductase in the goat lens in vitro then 
aqueous extract. 
Keywords: Quercetin; Abelmoschus Eesculentus Linn; Aldose reductase; Methanolic extract  
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REVERSE PHARMACOGNOSTICAL EVALUATION OF CISSUSQUANDRANGULARIS 
SHIKHA JAIN 1*, REVATHI ARUN GUPTA2, BHANWAR LAL JAT1 




Reverse pharmacognosy aim is to find new biological targets for natural compounds by virtual or real screening and identify natural resources that 
contain the active molecules. We report herein a study targeted on the chemical compounds available on C. quandrangularis responsible for 
antidiabetic activity. Molegro Virtual Docker (MVD) docking software was used to identify putative binding biological targets for binding of C. 
quadrangularis derived biologically active compounds. In the present study we focused on the identification of biological properties of 
parthenocissin a major component isolated from plant.  Among the 200 screened proteins five targets were retained: Peroxisome proliferator-
activated receptor alpha (4ema), Glucokinase (5brh), Glycogen Phosphorylase (1a8i), Dipeptidyl Peptidase IV (1orv) and Fructose-1, 6-
bisphosphatase (1umg). Binding test was realized for these five protein candidates as well as one reference. The predictions made by MVD were 
consistent with the experimental results, significance that these five targets can be modified by an extract containing this compound in an 
appropriate concentration. These results exhibit that reverse pharmacognosy and its inverse docking component is an influential tool to identify 
biological properties for natural molecules and hence for plants containing these compounds.   
 
 
Docking of parthenocissin with glycogen phosphorylase enzyme (1a8i) 
Keywords: Antidiabetic activity; Molegro Virtual Docker; Glucokinase; Reverse pharmacognosy 
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IN SILICO STUDIES ON PLANT DERIVED COMPONENTS OF CISSUS QUADRANGULARIS 
AGAINST GLYCOGEN PHOSPHORYLASE ENZYME 
SHIKHA JAIN 1*, REVATHI ARUN GUPTA2, BHANWAR LAL JAT1 




Cissusquadrangularis L. is a succulent plant of family Vitaceae commonly found in tropical and subtropical xeric wood. It is a fleshy, cactus-like liana 
widely used as a common food item in India. The plant is prescribed in the ancient Ayurvedic literature as a general tonic, analgesic, with specific 
bone fracture healing properties. Glycogen phosphorylaseenzyme is an oxidoreductase enzyme having a role in antidibaticresponses. The objective 
of this study was to show the drug-likeness and the binding of Cissusquadrangular is derived biologically active new compounds against the glucose 
level associated target glycogen phosphorylase enzyme. The 3D crystal structure of glycogen phosphorylase enzyme protein structure was taken 
from PDB database (PDB ID: 1a8i). Docking studies had been carried out through automated docking software MVD 2010, version 4.2.0. The 
compound shows interactive binding to the active site region of glycogen phosphorylase and  have better or equivalent binding features compared 
to already known inhibitory compounds namely Glibenclamide. These newly derived compounds from plant shows potential medicinal values with 
anti-diabetic properties which form understandings to develop new leads for glycogen phosphorylase inhibitors. 
 
 
Glycogen phosphorylase enzyme (PDB ID: 1a8i) 
Keywords: Cissusquadrangularis L.; Glycogen phosphorylase; Glibenclamide; PDB database  
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AIDS AN OVERVIEW CHEMOTHERAPY AND VACCINES 
SHIKHA SHRIVASTAVA*, SACHIN VERMA, JEEVAN PATEL, RAHUL JAIN 




A vaccine is any preparation that produce immunity by stimulating the production of antibodies..Injection is the common method of administrating 
vaccine.  Edward Jenner gave the term vaccine and vaccination. He showed that inoculating people with material from skin lesions caused by 
cowpox i.e. L.Vaccines of cows protected them from the highly contagious & frequently grave disease Small pox. These are kinds of vaccines are 
killed whole organisms, attenuated organisms or Toxoids Eg. Diptheria & Tetanus. Many different infections in people can be prevented by Vaccine 
for HIV. If a person is exposed to one of those germs later, the vaccine may protect them from getting infection. Thus, vaccines work by causing a 
person’s immune system. There are many difficulties in developing HIV vaccine.  The first & person   ever to be cured of HIV/AIDS is a leukemia 
patient treated in Berlin with HIV resistant stem cells. HIV infect a kind of white cell called a CD4  lymphocyte ,a key player in immune response 
what it makes HIV so devious is that it infect people  that are supposed to rub out viral infections. Most vaccine protects against disease, not against 
infection; HIV infection may remain latent for long periods before causing AIDS. 
Keywords: HIV Vaccine; Vaccination. 
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EVALUATION OF WOUND HEALING ACTIVITY OF POLYHERBAL OINTMENT 
DEEPA VARANDANI*, RAKESH BARIK, SAURAV JAIN 




In the present study, a poly herbal ointment was prepared and evaluated for wound healing activity. The various plants used were Nigella sativa, 
Linn. (seeds), Linum usitatissimum, Linn.(seeds), Psidium guajava (leaves) and Murraya koenigii (leaves). These were procured from the local 
market, Indore, and authenticated at Government Agriculture College, Indore. The plant parts were first defatted with petroleum ether and then 
extracted eith ethanol using soxhlet apparatus. The ointment was prepared by fusion method. Evaluation parameters were carried out for the 
prepared ointment. Primary skin irritation study was performed as per the standard procedure. The various moels used to study wound healing 
activity included dead space wound model and estimation of total hydroxyproline content. Histopathological study was also carried out. Higher 
hydroxyproline content was seen with polyherbal ointment treated group in dead space wound model. Increased amount of hydroxyproline was 
observed in treatment group justifying increased collagen content. Since hydroxyproline is the direct estimation of collagen synthesis it supports 
the wound healing activity of polyherbal ointment. The histopathology study also supplemented the results obtained. 
Keywords: Nigella sativ;, Linum usitatissimum; Psidium guajava; Murraya koenigii  
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FORMULATION AND EVALUATION OF HERBAL TOOTHPASTE 
MALVIYA SMRITI*, RAGHVENDRA DUBEY, PANKAJ NAGAR, YASHRAJ YADAV 




In addition to the herbal active ingredients listed above, most tooth pastes contain binders and preservatives to make sure they do not dry out. 
They also have different flavour ingredients, like mint, bubble gum, or cinnamon to make the toothpaste more pleasant to use. Whitening 
toothpastes may contain special abrasives that are designed to clean surface stains better than standard ingredients. Sensitive teeth toothpastes 
usually have ingredients like strontium chloride or potassium nitrate, which block pain receptors in your teeth. Through the action of mild 
abrasives all toothpaste helps to remove surface stain. Whitening toothpastes contain polishing agents to improve tooth appearance by removing 
surface stains. They do this through gentle polishing, chemical chelation, or some other non bleaching action. ADA seal on the toothpaste reviles 
that the toothpaste have been evaluated for safety and effectiveness. Herbal toothpaste is also one of the products. Toothpaste is the common 
product in our families and we hardly care to know about the product which we are using. Herbal toothpaste has numerous herbs which have 
ability to remove the plaque, freshen-up our breath and also prevent various gum diseases. No body wants to use chemicals, so we must go for 
natural alternatives available at least to save our tooth from decay. There are many advantages of herbal toothpastes. 
Keyword: Neem; Clove; Tulsi; Amla; Ginger; Lemon Calcium carbonate 
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PREPARATION AND EVALUATION OF SOLID LIPID NANOPARTICLES LOADED WITH 
CURCUMIN FOR TARGETED DELIVERY TO PANCREATIC CANCER 
RAKESH BARIK1*, SANJAY JAIN2, DEEPA VARANDANI3 
1 School of Pharmacy, GITAM University, Hyderabad.2Indore Institute of Pharmacy, Indore, Madhya Pradesh.3College of Pharmacy, 




The present study was aimed at preparation and evaluation of solid lipid nanoparticles loaded with curcumin for targeted drug delivery in the 
management of pancreatic cancer. Curcumin loaded SLN were prepared by hot homogenization followed by ultrasonication method. In these 
nanostructures, the drug can be entrapped or attached to the solid lipid nanoparticle matrix. Preformulation studies were carried out in terms of 
tests for identification, solubility and quantitative estimation of drug. For the anticancer study, the cell lines were procure from Indian Institute of 
Advance Research, Gandhinagar and in vitro cytotoxicity assay was performed. MTT assay was carried out to evaluate the anti cancer potential. The 
study showed positive results in terms of targeting the SLN loaded curcumin to the pancreatic cells as well as in the management of cancer. 
Keywords: Curcumin; Nanoparticles; Ultrasonication; In-Vitro Cytotoxicity  
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ANTIBACTERIAL POTENTIAL OF ETHANOLIC EXTRACT OF HOLOSTEMMA ADA KODIEN 
SCHULTS 
YASODHA KRISHNA JANAPATI1*, RAGHVENDRA DUBEY2 
1School of Pharmacy, Dept. of Medicinal Chemistry, Mekelle University, CHS,Ethiopia.2College of Pharmacy, Dr. A.P.J. Abdul Kalam 




The Ethanolic extract of Holostemma ada Kodien, family Asclepiadaceae was screened for antibacterial potential using disc diffusion method against 
both gram-positive and gram-negative bacteria at concentrations 20-100µg/ml. The extract showed zone of inhibition against Staphylococcus 
aureus, Micrococcus luteus, Salmonella typhi, Klebsiella pneumoniae, Escherichia coli and Pseudomonas aeruginosa. The Zone of inhibition was found 
at concentration 20, 40, 60, 80 and 100µg/ml. Extract was most active against Escherichia coli and least active against Bacillus substilis. The MIC 
found in the range 11-16 µg/ml.  
Keywords: Holostemma ada Kodien; Antibacterial activity; Disc diffusion method; Phyto-chemical studies. 
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FORMULATION AND EVALUATION OF HERBAL GEL CONTAINING COMBINATION OF 
TOMATO AND GINGER EXTRACTS AS AN ANTIHYPERPIGMANTATION AGENTS  
MEENA NILESH*, AGRAWAL ANKIT, GUPTA M K 




Tomato extract act as a free radical scavanger, inhibiting the destruction of extracellular molecules that counteracts the harmful effects of solar 
radiations whereas Ginger has a high antioxidant and restorative properties there by protecting the skin from sunlight’s radiation that can induce 
the hyperpigmentation and other skin related abnormalities. Tomato and Ginger extract has been proven in decreasing melanin content, but their 
single extracts effects were lower than their combination effect. This study aimed to investigate the anti-hyperpigmentation effect of the 
combination of Tomato and Ginger in a Herbal Gel formulation. The antihyperpigmentation activity from an ethanol extract of Tomato and Ginger 
gel showed by IC50 values. In this research we have been made the gel formulation from ethanol extract of Tomato and Ginger in various 
concentration : 1.0%, 2.0% and 3.0%. Based on the evaluation of the gel formulation we conclude that an ethanol extract from Tomato and Ginger 
can be formulated as gel formulation and has been fulfill the essential requirements of pharmaceutical formulation. From the three gel 
formulation we found that the three formulation has characteristics such as the stability on storage either in cold temperature (5oC) or room 
temperature (25oC), organoleptically, homogenity and pH. The result of this research, the IC50 value from the Gel contanining Tomato and Ginger 
extract is 234.16 μg/ml and the standard M® IC50 value is 185.34μg/ml. This value shows that the antihyperpigmentation activity from an 
ethanol extract of Tomato and Ginger extract gel is lower than the standard M®. But a single antihyperpigmentation activity from ethanol extracts 
of Tomato and Ginger it self has IC50 value 136.48 μg/ml. The ethanol extracts of Tomato and Ginger formulated in gel formulation were 
produced significant antioxidant activities and tyrosinase inhibition. The results demonstrated that the formulated herbal gel and its ingredients 
were consistent in quality and can be easily used as cosmetic product for its antihyperpigmentation effect . 
Keywords: Antihyperpigmentation; Enzyme Tyrosinase; Extracts of Tomato; Ginger. 
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DEVELOPMENT AND VALIDATION OF STABILITY INDICATING ASSAY METHOD FOR 
ESTIMATION OF DAPAGLIFLOZIN AND ITS DEGRADIENTS BY RP-UHPLC 
AVNISH JAIN*, LOVE K. SONI, RAJESH SHARMA 
School of Pharmacy, DAVV, Indore, MP 
Email: avnish.ajn@gmail.com   
 
Abstract  
This works aims to develop simple, accurate, precise, rapid and economical stability indicating RP-UHPLC assay method for Dapagliflozin which is 
sodium glucose co-transporter inhibitor used for the treatment of major metabolic disorder diabetes mellitus. In this method estimation was 
performed by using THERMO UHPLC with ultimate 3000 DAD detector fitted with Hypersil Gold C-18 column (150*4.6mm, 3microneparticle size). 
High resolution isocratic separation was achieved by using mobile phase consisting of Acetonitrile: di-potassium hydrogen phosphate with pH-6.5 
adjusted with orthophosphoric acid (50:50) at a flow rate of 1.25 ml/min. Retention time was found to be 1.35 min. with more than100000 N 
plates/meter column and tailing factor 1.05%. Dapagliflozin showed excellent linearity (r2>999) over 50-150 µg/ml concentrations. The force 
degradation of Dapagliflozin was carried out by using acid hydrolysis, base hydrolysis, oxidative degradation and thermal degradation. In all 
degradation conditions applied Dapagliflozin was well separated from its degradants. Study showed that there is significant degradation under 
oxidative and thermal conditions. This method was found to be simple, accurate, economical, robust and reproducible. This developed method has 
been validated for linearity, accuracy, precision, and LOD, LOQ and system suitability according to ICH guidelines. 
Keywords: Dapagliflozin; ICH guidelines; Hypersil Gold C-18 column; RP-UHPLC  
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FORMULATION AND EVALUATION OF AN ANTI-RETROVIRAL DRUG AS NANOCRYSTAL 
SUSPENSION USING TOP DOWN APPROACH 
RAJVEER BHASKAR1*, PRAKASH PATIL2 
R C Patel Institute of Pharmaceutical Education & Research, Shirpur, Dhule, Maharashtra.Institute of Pharmaceutical Education & 




Efavirenz is a non-nucleoside reverse transcriptase inhibitor and categorized in to BCS class II drug. Efavirenz exhibit low and variable 
bioavailability due to its poor aqueous solubility. So, it needs enhancement in the solubility, dissolution rate and bioavailability to derive its 
maximum therapeutic efficacy. The aim of the present investigation was to enhance the solubility, dissolution and stability of nanocrystal 
suspension (NCS) of efavirenz using a non-ionic stabilizer. Nanocrystal suspensions were prepared by high pressure homogenization technique 
(HPH) using PVP K 30 as stabilizer. Efavirenz was lyophilized and added to water to prepare micro suspension prior to homogenization step. 
Optimized NCS was evaluated for particle size, polydispersity index, zeta potential, surface morphology and drug release and pharmacokinetics 
parameters. Particles with average size of 49.3 nm, having PDI of 0.214 were produced. Which indicates good particles size distribution as the 
values obtained was below 0.4. Zeta potential value was found to be −31.2mV which shows good thermodynamic stability of optimized NCS 
formulation. Further results obtained from differential scanning calorimetry and an X-ray diffraction study again confirms the stability of NCS 
formulation. The release study revealed that 83.54±1.37% drug released from optimized formulation compared to 9.25±2.14% of physical mixture 
and 4.98±3.28% of pure drug. Optimized formulation exhibits first order drug release and mechanism of drug release was found super case II 
transport as ‘n’ value obtained 1.12 which is higher than 1. Animal study results reveals better permeation of drug compared to physical mixture 
and pure drug as peak plasma concentration of optimized NCS was found 2663.92±9.218 compared to 632.38± 5.621 of pure drug. Stability studies 
showed that there was no significant change in particle size, PDI, zeta potential and drug content over a period of six months as the values of 
particle size (48.58±2.01), PDI (0.220±0.008), zeta potential (-32.2±0.76) and drug content (97.6±1.67) were within range of the values of Zero day. 
Efavirenz nanocrystal suspension was successfully prepared by HPH method and evaluated against various parameters. Obtained results indicated 
its potential for an attempt towards successful nanocrystal formulation. 
Keywords: Nanocrystal suspension; High pressure homogenization; Drug release; Zeta potential 
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FORMULATION AND EVALUATION OF AN ORAL PYRAZINAMIDE CUBOSOME 
MONIKA OLA1*, V S BELGAMWAR2 
R C Patel Institute of Pharmaceutical Education & Research,Near Karvand Naka,Shirpur, District- Dhule, Maharashtra 425405.Dept of 




The objective of the present research work was to formulate and evaluate cubic formulation of Pyrazinamide to improve the bioavailability of the 
drug. It helps to increase patient convenience and reduction in the side effect of the drug by sustaining the release. By Top down approach using 
GMO as lipid phase vehicle, Poloxamer 407 as stabilizer and  distilled  water  as  aqueous  phase  by  varying  the  concentrations  of  GMO  and  
Poloxamer  407 different formulations of Pyrazinamide cubosomes  were prepared. The effect of stabilizer concentration was investigated to 
determine their effects on the morphological and dimensional characteristics of cubosomes. At the optimized homogenization conditions, 
Pyrazinamide cubosomes with a mean particle size of 180 nm±4.9 nm were obtained. The formulations were evaluated for particle size, surface 
morphology, encapsulation efficiency, in-vitro dissolution and diffusion studies. Structural evaluation was confirmed that loading of Pyrazinamide 
shows no disturbance in the structure of formed cubosomes. The encapsulation efficiency determined by UV spectroscopy and further confirmed 
that Pyrazinamide was successfully encapsulated in Cubosomes. 
Keywords: Pyrazinamide; Cubosomes; GMO; Poloxamer 407; Top down approach; Homogenization 
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NOSE TO BRAIN TARGETING OF NANOSTRUCTURE LIPID CARRIER OF QUERCETIN FOR 
TREATMENT OF BRAIN TUMOR 
NEHAL L. PATIL* 




Cancer is the most distressing and life threatening disease that enforces severe death worldwide. Brain tumour is the second leading cause of the 
cancer related deaths in children and young adults. Successful chemotherapy of cancer depends on the delivery of sufficient concentrations of an 
effective drug to tumour cells without causing intolerable toxicity to patient. Studies shows that direct delivery of the drug molecules from nose to 
brain is of vital impotence for the targeted delivery to CNS by bypassing BBB. Thus the aim of this study was to prepare and characterize quercetin 
loaded NLC and to study its brain distribution. The main objective of the study was to formulate nanostructured lipid carriers of the quercetin for 
direct nose to brain delivery of drug as tool for the targeted delivery. Novel QUE-NLCs were formulated using High Pressure Homogeniser. 
Formulation was evaluated for various physicochemical properties such as particle size, zeta potential, drug loading, percent entrapment efficiency, 
Morphology study, in vitro drug release profile, histopathology analysis. In vitro cytotoxicity against astrocytoma–glioblastoma cell line (U373MG) 
and brain distribution study was evaluated. QUE-NLC exhibited a particle size of 118.2 nm, with PDI of 0.220, zeta potential of -20.1mV, an 
entrapment efficiency of 88.74%. QUE-NLC exhibited sustained delivery of drug. Significant targeting to brain was achieved when compare to 
quercetin. The result showed that NLCs might be the promising approach for the nose to brain delivery of quercetin. 
Keywords: Quercetin; In-vitro cytotoxicity; High Pressure Homogeniser; Brain tumour  
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TRADITIONAL BENEFITS AND PHYTOPHARMACOLOGICAL SIGNIFICANCE OF PIPER LONGUM 
L. (PIPALAI) 
DARSHANA SHARMA* AND SUMEET DWIVEDI 




Plants have been the source of medicines since ancient history. Piper longum L. (Piperaceae), commonly known as pipalai (H) & long pepper (E), is 
widely distributed in India. The plant is native to be South Asia and is found both wild as well as cultivated, throughout India. Immature spikes 
(fruits), roots and seeds are used traditionally for the treatment of gastic troubles, during pregnancy and against microbial infection. In traditional 
system of medicine, the plant plays a unique role in the treatment of human and animal disorders. Plant contains large number of alkaloids and 
related compounds, the most abundant of which is piperine, together with methyl piperine, iperonaline, piperettine, asarinine, pellitorine, 
piperundecalidine, piperlongumine, piperlonguminine, refractomide A, pregumidiene, brachystamide, brachystamide-A, brachystine, pipercide, 
piperderidine, longamide and tetrahydropiperine, terahydro piperlongumine, dehydropipernonaline piperidine. The present reviews the traditional 
claims and phytopharmacological significance of the plant. 
Keywords: Traditional; Phytochemistry; Piper longum 
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INTERVENTIONS OF THE CLINICAL PHARMACIST IN THE TRANSITIONAL CARE ENTITY FOR 
PATIENTS 
MANDAN SAVITA SATISH*, KALAL CHETAN PURUSHOTAM, LADHAUMESHD 
R. C. Patel Institute of Pharmaceutical Education and Research, Shirpur, Dhule-425405, (MS) 
Email: a.mandan@rediffmail.com  
 
Abstract 
To discuss the role of the clinical pharmacist in hospital care of critical Renal Failure patients. Interventions by the pharmacists have always been 
considered as a important contribution by the health care community in the patient care process by reducing the medication errors, rationalizing 
the therapy and reducing the cost of therapy. The principal objective of this study was to definethe number of patients and prescriptions plan as 
well as types of prescription errors intervened by the dispensing pharmacists. Pharmacists provide services and clinical interventions must be 
shown to decrease the risk of potential adverse drug events and increase patient outcomes.This review proves that pharmacists may contribute to 
generous healthcare savings through a range of settings. Coming high-quality financialassessments with vigorous methodologies and study strategy 
are essential to design the pharmacist facilities haveimportant clinical advantages to patients and validate the highest cost savings for healthcare 
finances.Based on the outcomes we conclude that the role of pharmacist in refining the health care system is crucial. We mentionextra number of 
such research based studies to takeresponsiveness among health care professionals, deliver solution to the prescription and dispensing problems, 
as it can also improve the documentation system, emphasize the importance of it, reduce prescribing errors, &update the knowledge of pharmacists 
and other health care professionals. To determine the impact of clinical pharmacist intervention on the care of patients with Renal Failure disease, a 
potential design was applied to compare a standard care group with a clinical pharmacist care group using 50 Renal Failure patients per group over 
a 3-month period. The pharmacist responsible for patient counseling reviewed the patient records, collected demographic data, clinical data as well 
as medical history, diagnosis and medication plan. All interventions made by the clinical pharmacist were analyzed in terms of potential cost 
savings for the patient. Pharmacists’ intervention and comments written on the prescriptions and classify it into the following categories: (1) 
Change medication order; (2) Medication selection recommendation; (3) Prescribing medication without indication; (4) Therapeutic duplication; 
(5) Overdose; (6) Sub-therapeutic dose or duration; (7) Addition of another medicine; (8) Transcription error; (9) Administrative issues. In several 
cases pharmacists have intervened to reduce the cost of medications to improve the patient compliance and affordability. One of the best impact of 
clinical pharmacist providing patient counseling had a positive impact on medication adherence and quality of life.Intervention improved the 
balance between necessity and concern beliefs about medication, &efficiently resolved practical barriers in medication taking thereby improving 
medication. A clinical pharmacist intervention has a significant impact on the cost of drug therapy &patient outcomes. The results support the 
usefulness of pharmaceutical care services for all hospitalized Renal Failure patient. 
Keywords: Health of the elderly; Drug therapy; Critical care; Pharmacists intervention; Out-patient pharmacy.  
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PREPARATION AND EVALUATION OF ULTRATHIN MULTILAYERED CAPSULES FOR THE 
TOPICAL DELIVERY OF CISPLATIN 
ARTI MAJUMDAR1,2*, NIDHI DUBEY2, NEELESH MALVIYA1 




As the development of new molecule and to ensure their safety and efficacy is a time consuming process, drug delivery system is of particular 
interest. The aim of the present study is to develop smart, functional, organised self assembling nanostructures, ultrathin multilayered capsules 
with the potential to be used as drug delivery system for the topical delivery of cisplatin. These ultrathin multilayered capsules were formulated by 
consecutive adsorption of polyanion (0.1% Sodium alginate) and poly cation (0.1% Poly Allyl Amine Hydrochloride) on to core particles (0.2% 
Calcium Phosphate) The prepared ultrathin multilayered capsules were characterized for the shape and surface morphology, average capsule size, 
drug entrapment studies, percentage yield, zeta potential, In vitro release and stability studies. Optimized ultrathin multilayered capsules were 
loaded in carbopol gel and were evaluated for gelling properties. The shape and surface morphology of prepared ultrathin multilayered capsules 
were observed by using SEM and TEM. The average capsule size was found to be 8.4 ± 0.57µm. The maximum drug entrapment was found to be 
37.62 %. The percentage yield 72.12 %. The zeta potential of the capsule alternated between -20.4mv (Na alginate) and +29.6 mv (PAH) with each 
coating step, suggesting multilayered growth of the particles. Percent cumulative in vitro drug release was found to be 67.08 % after 24hrs. From 
the above study significant results were obtained and it can be concluded that the developed ultrathin multilayered capsules formulation show 
controlled drug release of cisplatin and thus helpful in reducing effecting dose and thus side effects. 
Keywords: Topical Delivery; Ultrathin multilayered capsules; Controlled drug delivery; Consecutive adsorption; Cisplatin 
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SYNTHESIS, CHARACTERIZATION AND IN VITRO ANTIMICROBIAL ACTIVITY OF SOME 
NOVEL SCHIFF’S BASE OF 1-BENZYL-7-AZAISATINS DERIVATIVES 
SIDDHARTHA KUMAR P1*, BASAVESWARA RAO M. V1, HARINATHBABU V2 
1Krishna University, Machillipatnam, Krishna district, Andhra Pradesh, India—521001.2G Pulla Reddy College of Pharmacy, 
Mehedipatnam, Hyderabad, Telangana, India. Email: siddarth.pharma@gmail.com 
 
Abstract 
From the literature, it is understand that Isatin (1H-indole-2, 3-dione) shows diverse significance in the field of restorative science as strong 
chemotherapeutic operators. The 7 aza isatin ring is a promising auxiliary moiety found in a few organic dynamic mixes. In this a progression of 
novel 7 aza isatin subsititutent joining distinctive aromatic aldehydes were combined and described by FTIR, 1H NMR, Mass spectroscopy and bases 
of essential investigation. Also, the in vitro antibacterial and antifungal properties were tried by utilizing the disc diffusion technique. A series of 
novel Schiff’s base of 7- aza isatin derivatives (Va-Vp) were synthesized by benzylation of 7-azaindole using Potassium hydroxide, dimethyl 
sulphoxide, benzyl chloride followed by oxidation of II using N-bromo succinimide, anhydrous dimethyl sulphoxide. Resultant III extracted by 
dichloromethane three times, then treat with 1-(4-aminophenyl)ethanone were dissolved in methanol in equimolar quantities and refluxed for 5 
hrs. On cooling, the crystalline solid separated out was collected IV; To this equimolar quantity of each of distinctive aromatic aldehydes, methanol 
added was refluxed for 24 hrs. to give  titled compounds. The chemical structures of synthesized compounds were confirmed by IR, 1H NMR, Mass 
and elemental analysis and these were screened for their in vitro antibacterial and antifungal activities. The results of antibacterial and antifungal 
activities showed that some of the synthesized compounds were exhibited promising antimicrobial activities. All the newly synthesized compounds 
were screened for antimicrobial activities by turbidity method using Ampicillin and Clotrimazole as standard against gram positive, gram negative 
bacteria and fungi. 
Keywords: Schiff’s base; 7-Aza Isatin; Antibacterial activity; Antifungal activity. 
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STRUCTURE-FUNCTION RELATIONSHIPS OF INHIBITION OF HUMAN CYTOCHROMES P450 
3A4, CYP2C9 BY 100 FLAVONE DERIVATIVES 
JUNAPUDI SUNIL1*, YASODHA KRISHNA JANAPATI2 
1Department of Pharmaceutical Chemistry, Geethanjali College of Pharmacy, Cherryal, Keesara, Ranga Reddy District, Telangana, 




In this study, we further examined and compared the structure-function relationships of the inhibition of human P450s 2C9, 3A4 and 2C9 with 
complex, with a total of 100 Phenolic compounds. The present studies show that structurally diverse flavonoid derivatives inhibit human P450 
CYP2C9, 3A4 and CYP2C9 in complex to different degrees, depending on the enzymes and inhibitors and that there are different mechanisms of 
inhibition of these P450s by flavonoids. The presents of bis-phenolic (bis-falvone: unix-26, 29, 61) groups was found to surpriselly increase 
inhibition potency toward these P450 enzymes. Some of a 5, 7-dihydroxyl group in the A ring of flavone was found to increase the inhibition 
potency toward these P450 enzymes (unix-4, 80). Molecular docking studies suggest that there are different orientations in the interaction of the 
six flavonoids with the five P450 enzymes examined and that two or more mechanisms are possible to explain how various flavonoids inhibit 
individual P450 enzymes differently. Molecular docking studies suggest that there are different mechanisms involved in the interaction of various 
flavonoids with the active site of P450s, thus causing differences in inhibition of these P450 catalytic activities by flavonoids. 
Key words: Flavonoids; Human cytochromes; Molecular docking, 
 
  
Vol 11, Issue 7, 2018 
 
Online - 2455-3891 
 Print - 0974-2441 
 
69 
Proceedings: Global Scenario in Pharmaceutical Industrial and Academic Research (Intellectual Property: Creation & Protection) GSPIAR 








IDENTIFICATION AND MOLECULAR DOCKING STUDY OF NOVEL THIAZOLIDINEDIONE 
ANALOGS AS ALDOSE REDUCTASE INHIBITORS 
JYOTI PANDEY1*, ARUN K. GUPTA2 





Aldose reductase (ALR) enzyme plays a significant role in conversion of excess amount of glucose into sorbitol in diabetic condition, inhibitors of 
which decrease the secondary complication of diabetes mellitus. The AR active site can adapts itself to bind firmly to special inhibitors; this happens 
together upon binding to the inhibitor’s hydrophobic, hydrophilic heads, and at the specificity pockets of AR, and capable to alter their nature 
through special conformational changes of the identical residues. Newer (E)-2-(5-(4-(benzoyloxy)-2-methoxybenzylidene)-2,4-dioxothiazolidin-3-
yl)acetic acid derivatives were applied for molecular docking studies. The molecular structure of aldose reductase active domain was arranged 
from the synchronized sets of 4LAU. The structure of protein and ligands were prepared using ChemBioDrawUltra 8.0. Docking method was done 
and optimized using software Molegro Virtual Docking (MVD).  A docking study was applied to envisage the interactions between the aldose 
reductase and designed series of compounds. Docking results were analyzed by comparing the moldock score, rerank score and hydrogen bond 
interaction. The results of this present study might be useful in the designing of more potent thiazolidinedione derivatives as Aldose Reductase 
Inhibitor. (E)-2-(5-(4-(benzoyloxy)-2-methoxybenzylidene)-2,4-dioxothiazolidin-3-yl)acetic acid analogs shows comparable ARI activity. These 
new class of thiazolidinedione compounds might be address the diabetic complications with safety.  
Keywords: Aldose reductase inhibitors; Docking; Diabetes mellitus; Thiazolidinedione 
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IN-VITRO ANTHELMENTIC ACTIVITY OF POLYHERBAL TABLET CONTAINING 
HYDROALCOHOLIC EXTRACT OF ABULTION INDICUM, HIBISCUS ESCULENTUS AND 
ABELMOSCHUS MOSCHATUS 
NEETU PANCHOLI1* AND SUMEET DWIVEDI2 




Helminthic infections are now being recognized as cause of many acute as well as chronic ill healths among the various human beings as well as 
cattle’s. More than half of the population of the world suffers from infection of one or the other and majority of cattle’s suffers from worm 
infections. Traditional system of medicine reports the efficacy of several natural plants in eliminating worms, keeping this view the present work 
was conceived by us to formulate and evaluate the effective anthelmintic drug. The present work was done with the aim to formulate polyherbal 
tablet in different batches viz., F1, F2, F3, F4 & F5containing hydroalcoholic extract of Abultion indicum (Leaves), Hibiscus esculentus (Flowers) and 
Abelmoschus moschatus (Seeds) and to evaluate anthelmintic activity of tablet using adult earthworm Pheritima posthuma. The tablet (F1 to F5) in 
different proportion of different concentration were tested which involve determination of paralysis time and time to kill the worms. Piperazine 
citrate was used as standard and it was found that the Polyherbal tablet (F4) having significant and maximum activity is when compared to 
standard drug. 
Keywords: Anthelmentic; Polyherbal tablet; Extract 
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A SYSTEMATIC REVIEW OF CLINICAL TRIALS OF A MEDICINAL PLANT FOR VARIOUS 
INDICATIONS 
YASHRAJ YADAV1*, NITESH JAIN1, RAGUVENDRA DUBEY2, RAJU CHOUKSE2 




To brief and critically evaluation of the evidence from various clinical trials for the safety and efficacy of individualized herbal medicine in different 
indication.  Literature Search for make rationalized electronic databases by Google Scholar, Pub Med, Science Direct and WHO ICTRP up to March 
2018. Extracted database have information of medicinal plant which has pharmacological properties and investigated under clinical trials of 
individualized or one or more combinational medicinal plant for various indication. The assessment of methodological quality by two or more 
authors and best evidence synthesis.  A total of 50 different herbal part and their product clinical trials were identified. Statistically, no significant 
trends favoring active over clinical treatment in various indication like pain swelling, arthritis, and another chronic disease Individualized 
treatment was superior to various outcome measures in the treatment of gastritis and irritable bowel syndrome but was inferior to standardized 
herbal treatment in all outcomes. Individualized herbal treatment was no better than placebo in the prevention of chemotherapy of tuberculosis 
and chemotherapy-induced toxicity. There is evidence regarding the effectiveness of individualized herbal medicine and no convincing evidence to 
support the use of individualized plant product in any indication 
Keyword: Medicinal plant; Clinical trial 
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OVERVIEW OF THE PATENTING AND RESEARCH AND DEVELOPMENT IN DEVELOPING 
COUNTRIES 
 RAKESH JATAV*, SANDEEP SALODKAR 




A patent is a property rights governed by sovereign state to the inventor of a novel, non obvious and useful invention. Developing countries 
historically have lacked the institutions and policies that encourage and make possible the patenting and commercialization of inventions of public 
sector employees. National patent offices of many developing countries are under-funded and under-staffed, making it difficult to achieve 
deliverables. Due to the cumbersome and expensive formalities of global patent, it is not impossible, for developing country inventors to obtain 
patent protection in the world’s big markets. The lack of Patent protection for pharmaceutical products in many developing countries also is a 
product of import substitution policies. These policies led to national pharmaceutical markets being dominated entirely by local companies copying 
the drugs of developed country inventors. Many developing countries have the capacity to build research-intensive pharmaceutical industries 
capable of operating profitably by providing products directed to the common to their own nationals that can be supported by the economics of the 
local market. Effective patent protection must be made available to the local industries, the commercialization of publicly funded research must be 
encouraged, and compulsory licensing must be kept to a minimum. These are measures to be incorporated for the strengthening of the local 
industries. 
Keywords: Inventor; Patent Protection; Import substitution; Research Intensive 
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PATENTING IN INDIAN PHARMACEUTICAL INDUSTRY: AN OVERVIEW 
SANDEEP SALODKAR*, RAKESH JATAV 




Intellectual Property (IP) is a kind of intangible property created with the efforts of human mind or intellect. Intellectual Property Rights (IPRs) are 
the rights derived due to creation of the intellectual property. These rights are conferred upon the creator (inventor, author etc.) of these 
properties. It should be noted that although the intellectual property is intangible but the material form of the intellectual property which is 
tangible can only be protected through IP rights. Patent is one of the major forms of Intellectual Property Rights (IPRs) used in the pharmaceutical 
industry.  IPR available in India are in the form of Trade mark, industrial design, geographical indication and copyright .Grant of patent in India is 
governed under the Patents Act, 1970. Significant changes were made time to time like provision of product patents after India signed TRIPS (Trade 
Related Aspects of Intellectual Property Rights) agreement in 1995. This review provides a brief overview of development of patent law in India as 
a consequence of TRIPS agreement. Criteria of patentability and different types of pharmaceutical patents currently being granted in India are 
described with the aim to provide the fundamental knowledge of pharmaceutical patenting to the researchers. The section 3(d) ensures that the 
new forms can be patented only if they are really meritorious, and thus patents shall not be granted for trivial inventions. It throws light on the 
Indian government’s policy of rewarding the inventors/ researchers on their true intellectual efforts and at the same time preserving the public 
interest and making them available essential commodities such as drugs at affordable prices. 
Keywords: Intellectual Property Rights; TRIPS; Inventor; Trivial Invention  
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GLOBAL SCENARIO IN PHARMACEUTICAL MARKET AND TRIPS 
SANDEEP SALODKAR*, RAKESH JATAV 




This paper gives the overview regarding the international controversy over patents and explores the implications of the 1995 Trade-Related 
Aspects of Intellectual Property Rights (TRIPS) agreement, the 2001 Doha Declaration, and the 2003 agreement preceding the Cancun meeting. 
These agreements do not resolve the important funding issues that developing countries confront as they seek access to drugs. Also, the 
international debate and its resolution will complicate the importing of foreign pharmaceuticals into the United States. The research-based 
pharmaceutical industry has argued that many of the relevant products are not on patent in the countries involved and that the problem is not 
patents but inadequacy of the medical infrastructure. The pharmaceutical industry views the patent system as essential to its business model. When 
a patent expires, the price normally falls as generic competitors enter the market. A number of developing countries, however, viewed patent law 
quite differently and deliberately decided to deny patent protection to pharmaceutical products and to grant protection only to processes for 
producing pharmaceuticals.  
Keywords: Doha Decleration; TRIPS; Patent System; Generic Competitors 
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MANAGING RESEARCH AND DEVELOPMENT IN PHARMACEUTICAL INDUSTRIES 
RAKESH JATAV*, SANDEEP SALODKAR 




The R&D managers strongly advocate R&D projects on a project-by-project basis. This literature suggests that projects should be managed 
differently depending upon project characteristics such as risk, ambiguity, and non routineness. While the primary emphasis of the R&D 
professional literature has been on project teams. This study investigates the influence of organizational controls on the research and development 
activities in pharmaceutical industries. This study is one of a handful of studies that simultaneously explores the use of input, behavior, and output 
controls. Two categories of innovation are considered as dependent variables: incremental innovations in the form of drug enhancements and 
radical innovations in the form of new drugs. Contrary to existing theory and hypotheses developed in this study, the results show that input, 
behavior, and output control enhanced radical innovation, and input and output controls enhanced incremental innovation. These results challenge 
several important features of existing models of R&D management and diverge from common beliefs about R&D management at the project level. 
While it is commonly accepted that incremental and radical innovation should be managed differently.  
Keywords: Research and Development Organizational Control; Incremental Innovation; Radical Innovation 
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INNOVATION AND PROFITABILITY IN PHARMACEUTICAL INDUSTRIES 
RAKESH JATAV*, SANDEEP SALODKAR 




This paper develops and test frame work for firm level profit persistence that embraces product innovation, product market competition.  
Sustained high profitability may result when a firm repeatedly introduces valuable innovation. Each innovation may erode over time; innovation 
ensures that overall the firm maintains a high performance position. At the same time sustained high profitability may also occurs to the firm that 
innovate less often  but effectively avoids competition  that otherwise erode high returns. The analysis sustained with the pharmaceutical industry 
find support for the expected relationship between high innovative propensity and sustained superior profitability, but no support for a link 
between ability to avoid competition and persistence.  
Keywords: Innovation; Superior profitability; Innovative Propensity 
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PROCESS VALIDATION OF NEBIVOLOL HYDROCHLORIDE TABLETS 
GIRIRAJ PATIDAR1*, REVATHI A GUPTA1, ARUN K GUPTA2 
1Sri Satya Sai Pharmacy Research Institute, Indore-Dewas Bypass, Arandia, Indore (M.P.), India.2School of Pharmacy, Dr. A.P.J. Abdul 




The main aim of the present research work was to study process validation of Nebivolol hydrochloride tablets 5 mg to provide documented 
evidence that the manufacturing process of “Nebivolol Hydrochloride Tablets 5 mg” meets the predefined control limits. This involves in-process 
observation of critical process and finished product analysis of present production can document confirmation to demonstrate that the 
manufacturing process is in a shape of control. The validation was conducted to provide the documented evidence and to provide the assurance 
that the Nebivolol Hydrochloride Tablets 5 mg can be manufactured at the commercial scale, meeting the all the quality attributes in the consistent 
manner. To demonstrate that the all the Critical Process Parameters (CPP’s) and Critical Quality Attributes (CQA’s) are found  complying 
predetermined criteria and shall produce the uniform drug product which is reproducible and consistent. Three consecutive commercial batches of 
was considered for process validation studies. The successful completion of the process validation study were provides the high degree of 
assurance that the process is capable of consistently producing the product to meet the predetermined specification for strength, identity, safety, 
purity and quality characteristics. Quality into the product task has built by the process validation method. Process Validation had proven to be an 
important tool for quality management of pharmaceuticals. 
Keywords: Nebivolol hydrochloride; Process Validation; Critical Quality Attributes 
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COMFA, COMSIA, HQSAR AND DOCKING ANALYSIS OF CHALCONES 
T. NARSINGHANI*, R. SHARMA, A. PANDIT 




Free radicals have been implicated in the etiology of several human diseases as well as ageing. These free radicals can be neutralized by a class of 
compound known as “Antioxidants”. Antioxidants may prevent and/or improve different diseased states. Chalcones constitute an important group 
of natural compounds that are shown to have varied pharmacological activities. Chalcones are known to inhibit tyrosinase enzyme. Presented 
herein is a comprehensive study on the structural requirements of chalcone derivatives for improved antioxidant activity. A dataset consisting of 
sixty-nine chalcone derivatives and their biological activity were subjected to CoMFA, CoMSIA and HQSAR analysis utilizing Sybyl X 2.0. The 
generated CoMFA, CoMSIA, HQSAR models displayed good statistical significance in terms of cross validation (q2) of 0.684, 0.689 and 0.947 and 
non-cross validation (r2) of 0.978, 0.977 and 0.947. The high and significant predicted r2 values of 0.684, 0.689 and 0.72 being obtained for CoMFA, 
CoMSIA and HQSAR analysis, giving an indication about the predictive ability of the developed models. Structure-activity relationship developed on 
applying these computational approaches revealed that electron releasing groups are favoured at ring A, while electron withdrawing group is 
favoured at position 2 of ring B and position 4 and 5 indicate the requirement of electron releasing group.  Steric bulk is not tolerated at position 2’ 
and 3’ on this ring, while steric bulk can be very well tolerated at position 2,4 and 5 of ring B. HQSAR contour map analysis depicted positive 
contribution of position 3,4 and 5 of ring B and medium contribution of position 2 of ring A. Docking analysis revealed hydrogen bond interaction 
between 2’-OH of ring A and oxygen of Met280. These results helped us in understanding the structural requirements for designing novel 
antioxidant molecules. 
Keywords: Chalcones; CoMFA; CoMSIA; HQSAR  
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FORMULATION, DEVELOPMENT AND EVALUATION OF NANOMIEMGEL FOR THE 
TREATMENT OF SKIN DISEASE: A REVIEW 
 SHIKHA JAISWAL*, REVATHI A. GUPTA 




In developing countries occur many types of health issue or various types of disease due to environment, incompatible diet and faulty foods. Among 
of disease one of the Skin disease are numerous and a frequently occurring health problem affecting all ages from neonates to elderly and cause 
harm in number of ways. There are number of skin diseases occur such as rashes, viral bacterial, fungal infections, cancer etc. In present 
methodology is to formulate, develop and evaluate of nanomiemgel for the treatment of skin disease. Nanomiemgel (NMG) is consist of two 
matrices A & B where matrix A is nanoemulsion (NEM) while matrix B is nanomicelle (NMI) Novel Drug Delivery System is better than conventional 
drug delivery system. Nanomiemgel is to develop a combination therapy as well as topical drug delivery system. The absorption of the combined 
system would be better than either of the individual drug delivery systems due to maximum possible paths of absorption available for that 
particular drug. Purpose of this study minimising toxic effect, reducing dosing frequency, better therapeutic effect, increase bioavailability, etc. 
Nano particulate systems to expect would be better skin permeation 
Keywords: Nanomiemgel; Nanoemulsion; Nanomicelle; Combination therapy 
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TOPICAL RETENOIDS: TAZAROTENE - AN OVERVIEW 
ANISH P. THOMAS*, RAGHVENDRA DUBEY, SMRITI MALVIYA 




Retinoids have been widely used for treatment of acne, psoriasis, skin aging, and certain types of cancers since their first introduction in the year 
1971. Retinoids are chemically derived from vitamin A and regulate numerous transcription factors including RAR and RXR located within the 
nucleus of various cells, alter the growth of the top layer of skin. Retinoids allow signaling to close proximity cells by binding the nuclear receptors, 
therefore regulating epithelial cell growth and rate of proliferation. The different topical retinoids available today are:  retinol, tretinoin, adapalene, 
tazarotene, alitretinoin, and bexarotene. These come in cream, gel, and liquid forms. Tazarotene gel can be applied to plaque psoriasis and has 
minimal systemic absorption. Unlike other retenoids, tazarotene is selective for retinoic acid receptor (RAR) proteins, with no affinity for retinoid X 
receptors. This may reduce unwanted effects, which are mainly local irritation of healthy skin with pruritus. Tazarotene should be avoided for 1 
month before conception, because of potential teratogenic effects.Tazarotene drug used on the skin to treat several skin conditions. It is also being 
studied in the treatment of basal cell skin cancer and basal cell nevus syndrome. Tazarotene is interconnected to vitamin A and is made in the 
laboratory. It turns on a gene that may help stop the growth of skin cancer cells. Tazarotene is a type of synthetic retinoid. A synthetic, topical 
retinoid Tazarotene induces the expression of tazarotene-induced gene 3 (TIG3), a tumor suppressor gene. In psoriasis, tazarotene normalizes 
abnormal keratinocyte differentiation and reduces their hyperproliferation. Tazarotene was the first topical retinoid approved for the treatment of 
plaque psoriasis in the United States; it was approved in 1997. It is available as a gel or cream in a concentration of either 0.1% or 0.05%.  
Keywords: Retinoic Acid Receptor (RAR); Vitamin D Receptor (VDR); Hormone Response Elements; Target Sequences; Retionoid X Receptor (RXR) 
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PHARMACOLOGICAL INVESTIGATION OF HAIR GROWTH PROMOTIONAL POTENTIAL OF 
PHYLLANTHUS NIRURI LINN. EXTRACT AGAINST DOXORUBICIN INDUCED ALOPECIA IN 
EXPERIMENTAL RATS 
RUCHI GUPTA*, NEELESH MALVIYA 




The present study was aimed to assess the hair growth promotion activity of Phyllanthus niruri in doxorubicin induced alopecia in experimental 
rats. The experimental protocol was designed for 20 days as per reported model of doxorubicin induced alopecia. At day 0 all hair follicles were in 
resting stage (telogen). Hair growth was induced by depilating the hairs with a hair remover cream. At 9th day after depilation; all follicles were in 
anagen VI stage. As soon as induced anagen follicles, i.e. on 9 post depilation, had reached early anagen VI, At the 9th day freshly prepared 
doxorubicin solution 2mg/kg was administered through intra-peritoneal route from 9th to 15th day in groups I, II and III. Hence, hair follicle 
dystrophy was induced after doxorubicin administration. Animals of groups- II, III were orally administered with 250mg/kg body weight of extract 
solution of petroleum ether of Phyllanthus niruri from 10th day upto 19th day. At 20th day of experiment all the groups were sacrificed and the 
histopathology of skin was conducted. Histopathology and gross morphologic observations for hair regrowth at shaved sites revealed active 
follicular proliferation. It was observed that the petroleum ether extract of Phyllanthus niruri Linn showed the ability to prevent damage to hair 
follicles by doxorubicin. Animal of groups II, III treated with extracts of plant showed hair regrowth. The study was concluded that extracts 
of Phyllanthus niruri Linn shown to be capable of promoting follicular proliferation or preventing hair loss in doxorubicin induced hair fall. 
Keywords: Doxorubicin; Phyllanthus niruri; Hair loss; Chemotherapy; Alopecia 
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VALIDATED HPTLC METHOD FOR THE DETERMINATION OF GLIPIZIDE IN COMBINED 
DOSAGE FORMS. 
GAJANAND ENGLA*, L.K. SONI 
School of Pharmacy, DAVV, Indore 
Email: gajanand54@gmail.com  
 
Abstract 
The developed and validated HPTLC method is simple, accurate, cost effective, and the statistical analysis proved that the method is reproducible 
and efficient for the analysis of Glipizide, in combined dosage form. The instrument Camag Linomat V semi automatic sample applicator, Camag TLC 
scanner 3, CATS V.4.06 software was used for the estimation, of the data. The pre coated silica gel G 60 F 254 was used as stationary phase. The 
mobile phase used was ethyl acetate: dichloromethane: formic acid (1:2:1 v/v/v), chamber saturation time 20 min, migration distance 70 mm, 
wavelength scanning was done at 275.5 nm. The band width of 8 mm, slit dimension 5±0.45 mm, scanning speed 20 nm/sec, and the source of 
radiation was a deuterium lamp. A good linear relationship was obtained over a concentration range of 200-800 ng/spot for Glipizide. The amount 
of Glipizide present in the three marketed formulations MI, MII and MIII was found to be 101.3±0.975, 99.8±0.625 and 99.65±0.755 respectively. 
The LOD for Glipizide was found to be 200 ng and the LOQ was found to be 0.339μg/ml. The linear regression data at a concentration range of 200-
800 ng/spot for Glipizide showed a good linear relationship. The RSD was found to be less than 2 for both inter-day and intra-day assay precision. 
The efficiency of the method is determined by means of number of theoretical plates. The number of theoretical plates was 3760 for Glipizide.  
Keywords: HPTLC; Glipizide; LOD; LOQ; %RSD; Rf value 
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MICROENCAPSULATION: A PROMISING TECHNIQUE FOR CONTROLLED DRUG DELIVERY OF 
THE DRUG 
SHIVANEE VYAS1*, RAGHVENDRA DUBAY2 




Microencapsulation is the process of surrounding or enveloping one substance within another substance, yielding capsules ranging from less than 
one micron to several hundred microns in size. The controlled release drug delivery system, release the active drug or medicament at a 
predetermined rate targeting the drug to specific site over a prolong period of time. The basic reason for the development & success of surrounding 
or enveloping technology depends on the better and accurate choice of the wall material. The core material may be encapsulated so that the core 
material will be released through the capsule walls, known as controlled released, or when external condition trigger the capsule walls to rupture, 
melt, dissolve. To develop and to enhance the growth for oral controlled release system, Microencapsulation technology is more desirable method 
for getting better results. The objective of this paper is to take a closer look at micro particles as drug delivery device to improving the release 
profile and the drug targeting, mechanism of drug release, type of coating material, techniques for the preparation of microcapsules and its 
applications. 
Keywords: Microencapsulation; Controlled drug release system 
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SYNTHESIS AND ANTIMICROBIAL SCREENING OF SOME N-(5-OXO-2-ALKYL/ARYL- 
IMIDAZOLIDINE-1-YL) ISONICOTINAMIDE DERIVATIVES 
RAKESH PATEL1*, ANIL BHANDARI2 




New derivatives of isoniazid; N-(5-oxo-2-alkyl/aryl-imidazolidine-1-yl) isonicotinamide have been synthesized and they are evaluated for their 
Antifungal, Anti-tubercular and Anti-bacterial activity. Compounds were synthesized by substituting isoniazid (Schiff Base) by the reaction of 
isoniazid with substituted aldehydes and substituted isoniazid (Schiff Base)  then react with amino acitic acid in the presence of 1:4 dioxane to give 
various isonicotinamide derivatives. Synthesized compounds showed significant activity against bacterial, fungal and mycobacterium strains. Their 
structures were established on the basis of elemental analysis, IR, 1H NMR and Mass Spectral data. 
Keywords: Imidazolidine; Isoniazid; Anti-mycobacterial 
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SYNTHESIS OF HIGHLY SUBSTITUTED INDENE’S FROM ARYL VINYL ALCOHOL 
SHIVENDRA S. RAGHUWANSHI*, ANKUR JOSHI, SAPNA MALVIYA, ANIL KHARIA 




The aim of present work was to synthesis and characterization of highly substituted Indene’s from Aryl Vinyl Alcohol. Cyclopentane motif is a 
privileged structure because of its widespread occurrence in many synthetic organic molecules and biologically active natural products such as 
prostaglandins, steroid, and terpenoid, etc. The classical approach towards the construction of cyclopentenone rings is the Nazarov Cyclization, a 
cationic electrocyclization that converts divinyl ketones to cyclopentenones by activation with protic or Lewis acids. Electrocyclic reactions are a 
powerful synthetic transformation with the ability to create new carbon-carbon bonds stereospecifically by the simple orbital reorganization. 
Synthesis of tertiary hydroxyl containing aryl, vinyl, and methyl and their application in the synthesis of highly substituted indenes were described. 
We envisioned that highly substituted indenes could be synthesized from aryl vinyl alcohols. Aryl vinyl alcohols can be obtained from aryl vinyl 
ketone by adding organolithium reagent as shown in the retrosynthetic analysis.We have accomplished several highly substituted indenes, and all 
new synthetic compounds were well characterized by using 1H NMR, 13C NMR, ESI-LCMS, and IR..For the biological investigation, all compounds 
were submitted to National mole bank of CSIR-IICT with high purity and results of biological activity yet to obtain.  Indene, a polycyclic compound 
consisting of benzene ring joined with cyclopentene ring represent an important and structural unit in various biologically active compounds. The 
importance of this class of molecules gets further impetus due to their involvement as starting material in the synthesis of various biologically 
active scaffolds. Indenes exhibit a broad spectrum of biological activity. They also serve as precursors for synthetically and biological important 
indenones and many other potential scaffolds such as steroids or gibberellins. 
Keywords: Cyclopentane;  Nazarov  Cyclization; Indene  
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SGLT-2 RECEPTOR: A POTENTIALLY NOVEL TARGET FOR TREATMENT OF TYPE 2 DIABETES 
MELLITUS 
STEFFY MARY CHANDY*, REVATHI A GUPTA 




In the 21st century Type 2 diabetes mellitus is establishing itself as an epidemic and most of the currently available antidiabetic drugs are associated 
with a higher risk of ischemic cardiovascular events, including myocardial infarction and stroke, and microvascular events, including nephropathy 
and retinopathy. Thus it is very important to fine better and safer oral drugs for treatment of Type 2 Diabetes mellitus. From recent study it has 
been found that Sodium Glucose Cotransportor 2 inhibitors have lower cardiovascular risk and shows its action apart from glucose lowering alone. 
SGLT-2 inhibitors show an insulin dependant mechanism to reduce the hyperglycemia and helps in treatment of hyperglycemia with lower risk of 
hypoglycemia. A review on pharmacophore study of SGLT-2 inhbitors has shown that diarylmethane C-glucoside is one of the excellent SGLT-2 
inhibitor. The study of active micro-molecules of Sodium Glucose Cotransporter 2 provides guidance for designing of novel SGLT-2 Inhibitors. The 
optimal pharmacophore model contained seven pharmacophore features. The study shown that one hydrogen-bond donor, one hydrogen-bond 
acceptor and five hydrophobic groups are essential for inhibiting SGLT-2 receptor. SGLT2 inhibitors have offered a new fundamentally different 
approach for treatment of Type 2 diabetes mellitus with lower cardiovascular and hypoglycemic risk. The clinical results suggest this class of 
inhibitors could be safely used for non-renally impaired patients at any stage of T2DM either alone or in combination with other marketed 
antidiabetic medications. 
Keywords: Imidazoquinoline; Pharmacophore; Antidiabetics; DPP-IV inhibitors 
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OPTIMIZATION AND VALIDATION OF RP-HPLC METHOD FOR THE ESTIMATION OF 
CHLORZOXAZONE AND PARACETAMOL WITH ITS GENOTOXIC IMPURITY (4-AMINO 
PHENOL) IN BUL AND PHARMACEUTICAL DRUG PRODUCT USING PDA DETECTOR 
 
SANJAY JAIN*, LOVE. K. SONI 
  School of Pharmacy, Devi Ahilya Vishwavidyalaya, Indore (MP), India. B R Nahata College of Pharmacy, Mandsaur (MP) 458001, India 
 Email:sanjay.jain@meu.edu.in  
 
Abstract 
Paracetamol and chlorzoxazone are frequently associated in pharmaceutical oral formulations. These active compounds have different polarity and, 
therefore chromatographic method development is cumbersome and is further complicated by the presence of impurities such as 4-aminophenol 
related to paracetamol. The dosage forms also contain excipients, some of which may interfere with the analysis of the active ingredients. No single 
method is reported to determine the active ingredients quantitatively in this combination with a check on p-amino phenol (genotoxic impurity) in 
formulation. A simple, accurate, precise, reproducible RP-HPLC method has been developed for simultaneous estimation of chlorzoxazone (CZX) 
and paracetamol (PCM) with its genotoxic impurity, p-amino phenol (4-AP) in bulk and combined dosage form (tablet). The method was validated 
in compliance with ICH guidelines. The LC separation was achieved on LiChrospher RP-18e (250X4.6mm), 5µm column at 279 nm in isocratic mode 
using mobile phase composition methanol: acetate buffer (60:40 v/v), pH adjusted to 5.5 by acetic acid. Flow rate employed was 1.0 ml/min. The 
retention time for paracetamol, chlorzoxazone and 4-amino phenol were found to be, 3.76, 6.20 and 2.75 minutes respectively. Linearity ranges for 
paracetamol, chlorzoxazone and 4-amino phenol were established in the range of 10-50 µg/ml, 10-50 µg/ml and 0.8-2.8 µg/ml respectively with 
correlation coefficient of 0.997, 0.996 and 0.999 respectively. The % recoveries for paracetamol, chlorzoxazone and 4-amino phenol impurity were 
found in range with relative standard deviation (RSD) less than 1. The LOD and LOQ were found to be 1.1483 and 3.4798 for paracetamol, 1.3890 
and 4.2092 for chlorzoxazone and 0.01459 and 0.0442 for p-amino phenol respectively in µg/ml. The proposed method is successfully applied for 
the quantification of paracetamol, chlorzoxazone and 4-amino phenol impurity in bulk and formulations.  
Keywords: Chlorzoxazone; Paracetamol; 4-Amino phenol impurity; Photodiode array detector 
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DESIGN & CHARACTERIZATION OF METFORMIN HIDROCHLORIDE MICROSPHERES USING 
SOLVENT EVAPORATION TECHNIQUE 




The design & Characterization of Metformin Hidrochloride Microspheres using Solvent Evaporation Technique was performed. Metformin HCl 
microspheres were prepared by solvent evaporation technique using various polymers including ethyl cellulose, Hydroxypropyl methylcellulose, 
and chitosan to improve the bioavailability, reducing the dosing frequency and to improve the patient compliance of drug in comparison with other 
conventional dosage forms. The effect of process variables like drug entrapment efficiency, stirring rate, drug content, yield and drug release profile 
were studied. It was observed that an increment in stirring speed decreases the size of microspheres and increases the release of drug from 
microspheres. It was concluded that the various degree of sustained release of metformin was obtained for microspheres prepared with ethyl 
cellulose, HPMC, and chitosan from which the microspheres prepared with chitosan has the most drug sustaining property then other formulations. 
Therefore, the developed microspheres prepared by solvent evaporation technique shows the sustained oral drug delivery of metformin HCl.   
Keywords: Metformin HCl; Microspheres; Sustained release; Solvent evaporation technique  
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SYNTHESIS AND CYTOTOXICITY ASSAY OF CHRYSIN DERIVATIVES AS ANTICANCER ACTIVITY 
SURESH CHAND DANGI*, SUDHA VENGURLEKAR 




Chrysin derivatives have been extensively studied to explore their potential utilization in chemoprevention.  The main objective of the present work 
is to perform a Synthesis and Cytotoxicity Assay of chrysin derivatives. Chrysin derivatives were synthesized and cytotoxicity study by MMT Assay. 
Cancer is a group of diseases that characterized by uncontrolled growth and multiplication of abnormal cells. Several techniques have been adopted 
for the treatment and eradication of cancerous cells. These techniques involved surgery, radiation, immunotherapy, chemotherapy and 
chemoprevention. Without harming normal tissues ideal anticancer drugs would eradicate cancer cells. Chrysin, also known as 5, 7-
dihydroxyflavone with an IUPAC name of 5,7-dihydroxy 2-phenyl-4H-chromen-4-one, belongs to the flavone sub-class of flavonoids. Its chemical 
structure is essentially based on a three ring nucleus with a phenyl ring attached to position 2 of the fused bicyclic and rings. Flavonoids including 
flavones, flavonols, and flavones possess various biological activities as Antioxidant, anticancer etc. chrysin as a flavonoids shown activity for 
anticancer activity. Acylation of chrysin was done with the aim to protect hydroxyl groups to have more bioavailability of chrysin derivatives and 
cyclic moieties were included in order to have more lipophilic character and synergistic effect towards anticancer activity. Overall compound have 
shown better potential as anticancer agent, however, further investigation of the in vivo activity and toxicity studies is necessary to elucidate the 
mechanisms of action and the efficacy of compound further. 
Keywords: Chrysin; Cytotoxicity Assay; Flavonoids; Antioxidant; Anticancer 
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ROLE OF PATENT AND EXPIRATION IN PHARMACEUTICALS 
ABHISHEK MISHRA*, RAGHVENDRA DUBEY  




Pharmaceutical is highly lucrative market in the terms of intellectual property rights. The patent is an exclusive right granted to the inventor by the 
specific government of the country for the utilization of invention for commercial use. Patent is the protection of the invention intellectually 
generated by inventor. The patent helps prevent the replication of manufacturing and sell of the pharmaceuticals without the legal permission of 
the inventor till the patent expires which is normally up to 20 years. While getting the patent for any pharmaceutical will provide the full rights to 
inventor to use the medicine and gain the monitory benefits. In current scenario every year new lives saving drugs are being introduced and patent 
has given consistent growth to the industry for the manufacturing and sale of the new products. The inventor has individual right for his invention 
and the price of the invention includes money spent on research and development of invention. The patent can be applied by individual and jointly 
by two or more than two inventors to whom the inventor has assigned the invention.  
Keywords: Patent; Intellectual Property Rights; Inventors; Pharmaceutical 
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MICROWAVE ASSISTED AQUEOUS EXTRACTION OF STEM BARKS OF ZIZIPHUS SPECIES 
RAGHVENDRA DUBEY1*, KUSHAGRA DUBEY2 




Dried Stem barks are hard and their cellular structure is less impermeable for solvent extraction. Maceration for longer period may results in 
extraction of chemical constituents from such samples which is time consuming process. In the present work an attempt was made to increase the 
penetration of the solvent via irradiating with microwave radiation to increase the extraction and to reduce the overall time of extraction. The Dries 
barks of Ziziphus mauritiana and Ziziphus nummalaria were subjected to aqueous extraction under microwave assisted extraction in borosil 
glassware. The microwave was set to minimum 20% heating for the period of 60 sec and 2mins. The procedure was repeated and the product 
obtained was dried. The product was compared with the convention extraction of the stem barks of species. The results clearly indicate that the 
extractive value of Ziziphus stem barks were increase 2.3 fold greater than conventional method. The overall time of extraction is reduced to 4%. 
The comparative phytochemical screening of extracts from conventional & microwave assisted extraction confirms the presence of same 
constituents however the amount of extract is found more in microwave assisted extraction. The microwave aqueous extraction is safe and effective 
method for the extraction from stem barks. 
Keywords: Ziziphus mauritiana; Maceration; Ziziphus nummalaria; Phytochemical Screening 
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TAZAROTENE: A TOPICAL RETENOIDS AGAINST COMEDONES FOR THE MANAGEMENT OF 
ACNE 
ANISH P THOMAS, RAGHVENDRA DUBEY* 




Acne is one of the common diseases observed in youngsters and sometime non curable for the longer period of time. For the management of acne 
topical retinoids acting on comedones and microcomedones are used. The retinoids are generally derived from vitamin A, tretinoins and 
isotretinoins. They regulate transcription factor, intercellular communication, epithelial cell growth and rate of proliferation. Trazarotene, synthetic 
retinoid, is potent medicine used for the treatment of acne which act on retinoic acid receptor (RAR) proteins and have no affinity for retinoid X 
receptors. Binding to retinoid X receptor generally results in unwanted side effects such as erythema, dryness, itching and stinging hence the 
trazarotene reduces sideeffects. Tazarotene is also used in the treatment of psoriasis, basal cell skin cancer, basal cell syndrome and other skin 
diseases. It is available in cream and gel formulation in a concentration of 0.1% or 0.05%.  
Keywords: Trazarotene; Retinoids; Microcomedones; Retinoids 
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FORMULATION AND EVALUATION OF FLOATING MICROSPHERES OF BOSWELLIC ACID BY 
SOLVENT EVAPORATION METHOD 
RAJU CHOUKSE*, DEEPIKABAIRAGEE, SWETA KULKARNI, ARUN K GUPTA 




The aim of the present research work was to formulate  and evaluate floating microspheres using boswellic acid as drug.Boswellic acid is a 
lipophillic drug hence  it is absorbed  rapidly  from  the  stomach and having  the half  life of  6 Hrs. The microspheres were prepared by the solvent 
evaporation method using polymers Eudragit RS 100 in fixed ratio and Ethylcellulose in variant ratios. Drug and polymer compatibility study was 
done by TLC and IR spectroscopy. The Percentage  yield  ,Particle  size  distribution, Buoyancy  percentage, Entrapment  Efficiency  and In  vitro 
drug  release studies were  performed and drug release kinetics  was evaluated using the linear  regression method.  The prepared microspheres 
exhibited prolonged drug release for about 18h and remained buoyant for more than 12 h.  As the mean particle size increases, the drug release 
rate decreases at higher polymer concentration. The floating microspheres followed zero order kinetics and the mechanism of drug release was 
governed by peppas model.  
Keywords: Microspheres; Boswellic Acid; Buoyancy; In-Vitro Studies; Diffusion- Controlled Drug Release  
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ENDOTHELIN-A RECEPTOR ANTAGONIST AS ANTIHYPERTENSIVE AGENT 
ANAND PANCHAL*, PAWAN CHOUDHARY, STEFFY MARY CHANDY, REVATI A. GUPTA 




The local vasoconstrictor substances are of endothelial origin and are known as endothelins (ET). The production of endothelins is because of the 
stretching of blood vessels. Endothelin-A exerts pro-inflammatory, profibrotic and hypertensive properties on heart, blood vessels and kidney. 
Hence Endothelin-A receptor antagonist have a potential to reduce blood pressure and different complications occurred due to hypertensive 
diseases. Endothelin-A receptor antagonist may contribute to its therapeutic potential in hypertension and other disorders like diabetes and renal 
failure. They have different other disorders too like fibrosis, atherosclerosis, inflammation, cardiovascular growth and diabetes. The aim of this 
study is to compare the effect of BMS-182874 on selective Endothelin-A receptor antagonist in hypertension. BMS-182874 had no effects on 
changes in mean arterial pressure brought about by vasoactive agents. But they specifically effect on inhibiting the pressor response to Endothelin-
A in Sprague-Dawley rats in a dose dependent manner. The effect of the BMS-182874 is on deoxycorticosterone acetate(DOCA) which is a type of 
steroidal hormone formed in adrenal gland in a salt hypertensive rats, spontaneously hypertensive rats (SHR), and sodium-deplete SHR.  BMS-
182874 generally reduces blood pressure in salt hypertensive rats when given at a dose of 30, 45, 75,100,300μmol/kg IV. Maximum upto reduce of 
45mm of Hg is observed  after the time interval of 3 days in a hypertensive rats when given dose of 100μmol/kg IV via intravenously. Thus, 
Endothelin-receptor activation may play a role in volume-dependent or low-renin hypertension but is unlikely to be important in all hypertensive 
states. 
Keywords: Endothelins; Hypertension; Deoxycorticosterone acetate 
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SPACE MEDICINE – A REVIEW 
A CHATURVEDI *, P.K. DUBEY, S. AGRAWAL, N. GUPTA 




Space Medicine has evolve to support the presence of human being in space, which is an environment not designed for human being. Evidence 
based Medicines, lessons from research and clinical experience were the principal drivers behind the never ending effort to secure astronauts lives 
and understand how the space environment influences human physiology.  
To understand and solve the problems of astronauts encountered in space i.e. physiological and psychological problem, such as Motion sickness, 
negative nitrogen, calcium balance, anemia, Radiation exposure are the issues that are already affect medical practice.  
Keywords: Space medicine; Motion sickness; Calcium balance 
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DESIGN, SYNTHESIS AND INVESTIGATION OF NITRO ARYL/ NITRO HETEROARYL ANALOGS 
AGAINST LEISHMANIASIS 
RAKESH KUMAR JATAV1, ARUN KUMAR GUPTA2 
1College of Pharmacy, Dr. A. P. J. Abdul Kalam University, Indore . 2School of Pharmacy Dr. A. P. J. Abdul Kalam University, Indore . 
 
Abstract 
Historically, the pharmaceutical industry has relied upon discovering drug leads by screening and sifting through vast inventories of naturally 
occurring and man-made chemicals in search of previously undiscovered substances with the desired biological activity. Conventionally, 
optimization of the lead is achieved by random exploration of the chemical structure through the synthesis of large numbers of chemical 
derivatives. Considering both the potential benefits to human health and the enormous cost in terms of time and money for drug discovery, any tool 
or technique [High throughput Screening (HTS), Combinatorial chemistry and Molecular Modeling], that increased the efficiency of drug discovery 
enterprise will be highly prized. Nobody could design a drug before knowing more about the disease or infectious process. For “rational” design the 
first necessary step is the identification of a molecular target critical to a disease process or an infectious pathogen. Then the important prerequisite 
of “drug design” is the determination of the molecular structure of target, which makes sense of the word “rational Therapy to treat patients with 
leishmaniasis still poses a series problem. The drugs of first choice are pentavalent antimonies compounds, which were developed before 1960, and 
in general, require long-term treatment and have severe side effects. Second-line drugs, such as Amphotericin B and its lipid formulations, are 
either too toxic or expensive for routine use in developing countries. At the same time, the efficacy of Miltefosine against cutaneous leishmaniasis 
remains to be ascertained. The reported large-scale clinical resistance to antimonial agents in India and Sudan has created an urgent need for the 
development of safer, cheaper, and more effective new anti-leishmanial drugs. The study will generate novel & potent ant-Leismania agents, which 
will be cost effective, & of lesser side effects. The employment of rational drug design will ensure that the generated drug candidates will be 
selective towards the cells and will seldom act on normal cells. The study will also generate lead molecules, which might be prospective drug 
candidate for the treatment of Leishmaniasis.  
Keywords: Leishmaniasis; Nitro aryl/ Nitro heteroaryl Analogs; High throughput Screening 
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MICROBIAL LIMIT TEST OF DIFFERENT PATHOGENS FOR    WATER SAMPLE 
POONAM JAISWAL*, SMIRITI SOHANI 
Department of microbiology, I.K.D.C.College, Indore 
Email: jaiswalpoonam274@gmail.com 
                                                                                                                            
Abstract 
Bacteriological water analysis is a method of analyzing water to estimate the number of bacteria present and, if needed to find out what sort of 
bacteria they are it represent are aspect of water quality. It is a microbiological analytical procedure which uses samples of water and from these 
samples determines the concentration of bacteria. It is then possible to draw inference about suitability of the water for this concentration.  The 
pure water free from of pathogen organism is called potable water. It is used for drinking water is obtained from rivers, streams, lake, 
wells,borewell e.t.c. normally, the coliform bacteria are considered as the indicaters of pollution of drinking water. These live in the human colon of 
these Escheria coli is important and it is released through feaces. The presence of E.coli, on the water indicates pollution. Potability of water is 
determined by bacteriological test.  
Keywords: Escheria coli; Pathogen organism; Coliform bacteria 
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JAGRUTI: AN EDUCATIONAL INTERVENTION TO SAFEGUARD REPRODUCTIVE HEALTH OF 
ADOLESCENT GIRLS 
KALPESH R. PATIL1, PRIYANKA V. PATIL2, AACHAL S. MAHAJAN1, AISHWARYA S. BHAVSAR1 
1H. R. Patel Institute of Pharmaceutical Education & Research, Shirpur,  Dhule, MH, India.2Bombay College of Pharmacy, Kalina, Santacruz 
(E), Mumbai-400098, MH, India 
 
Abstract: 
Objective of study was to assess the knowledge level of adolescent girls about menstruation, status of hygienic menstrual practices and socio-
culture restriction followed during menstruation. Study is aimed to develop Jagruti-awareness programme and assess its impact on knowledge 
level about menstruation, promotion of safe and hygienic menstrual practices, and overcoming of restrictions and taboos. Community based, 
cross-sectional interventional study was conducted in selected population of adolescent girls from North Maharashtra. Self-prepared and 
validated questionnaire consisting of components like demographic information, knowledge about menstruation, socio-cultural restrictions and 
hygienic practices during menstruation were administered to the participants of study. Following collection of pre-test data, Jagruti was conducted 
for adolescent girls. Programme consisted of steps like dissemination of information through interactive lecture by female facilitator, screening of 
animated video, individual counseling, question answer session and display of awareness posters. Post-test data was collected through 
questionnaire to evaluate the impact of Jagruti awareness programme on the knowledge, attitude and practices of respondents about menstruation. 
Statistical analysis was done through Fisher's exact Chi-square test. It was observed that prior to implementation of Jagruti (pre-test), 
adolescent girls had poor knowledge about menstruation, girls were following many socio-cultural restrictions and adopted incorrect 
hygienic practices. Only 57% of students were knowing about menstruation, 16.94% respondent were correctly identified that uterus is 
source of menstrual bleeding, 81.83% considered that menstruation is normal event and 46.29% knew that menstruation gives ability of 
reproduction. Before, Jagruti programme, 60.10% respondents stated that they wash their external genitalia during bathing only, 54.96% 
adolescent girls used only water for cleaning the private part and only 50.0 % girls used sanitary pads during menstruation. Whereas, in the post-
test period i.e. after the completion of Jagruti programme, notable enhancement was observed in the knowledge level and hygienic menstrual 
practices of adolescent girls. Significant (P<0.0001) difference was noticed in the attitude of adolescent girls, before and after the conduction of 
Jagruti programme, towards socio-culture restrictions like communication with male members, cooking food, doing daily work, outdoor activities, 
etc. Jagruti programme has positive impact on adolescent girls regarding knowledge, attitude and practices about menstruation and menstrual 
hygiene. Jagruti is effective educational tool for spreading awareness about female reproductive health. 
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